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ABSTRACT
Parenteral structured triglyceride emulsion: Safety, tolerance, and effects on
nitrogen balance and immunology.
PhD thesis by Joanna Kruimel, Department of Gastroenterology and Hepatology,
University Medical Center Nijmegen, The Netherlands, October 6th 2004.
Total parenteral nutrition is complete nutrition intravenously administered to
patients, incapable of adequate food absorption. An important component in this
total parenteral nutrition is the parenteral lipid emulsion. We studied a newly
synthesized parenteral lipid emulsion: structured triglycerides. Structured
triglycerides consist of triglycerides where the medium-chain and long-chain fatty
acids are at random attached to the same glycerol backbone. The aim of our study
was to investigate safety, tolerance, and effects on nitrogen balance and
immunology of structured triglycerides. 
We performed a randomized, double-blind trial on 25 moderately catabolic
patients, comparing structured triglycerides with a physical mixture of medium-
chain and long-chain triglycerides, as part of 5 days post-operative parenteral
feeding. No difference in safety and tolerance between the two emulsions was
observed. In the patients who completed the study, the mean cumulative nitrogen
balance over the first 5 post-operative days was significantly better in the structured
triglyceride group (-8 ± 2 g in 10 patients on structured triglycerides and -21 ± 4 g
in 9 patients on the physical mixture, p = .015). Structured triglycerides were
cleared faster from the blood on the first post-operative day, resulting in lower
serum triglyceride levels and lower plasma medium-chain free fatty acid levels,
compared with the physical mixture.    
The effect of structured triglycerides on immunology was studied by measuring
the phagocytosing capacity of the mononuclear phagocyte system and the
production of cytokines and oxygen radicals. The phagocytosing capacity of the
mononuclear phagocyte system (MPS) was studied in 13 patients by measuring the
clearance of 99mTc-S-colloid from the blood and did not change during infusion of
structured tiglycerides or the physical mixture. The cytokine production was
studied in 18 patients: the effect of surgery overwhelmed the effect of nutrition,
making conclusions on the effect of the lipid emulsions on cytokine production
impossible. Instead, we demonstrated a downregulation of production and release
of pro-inflammatory cytokines during surgery. Finally, in-vitro stimulated
polymorphonuclear leukocytes from 10 volunteers pre-incubated with the physical
mixture showed higher levels of oxygen radicals (p < .005) and faster production of
oxygen radicals (p < .005) measuring chemiluminescence, compared with
polymorphonuclear leukocytes pre-incubated with structured triglycerides or
long-chain triglycerides. High levels of oxygen radicals can be detrimental in case
oxygen radicals play a pathogenic role or beneficial when rapid phagocytosis and
killing of bacteria is needed. 
In conclusion, parenteral structured triglyceride emulsion was a safe and well-
tolerated emulsion, and had a better nitrogen balance and was cleared faster from
the blood than the physical mixture. In-vivo phagocytosing capacity of the MPS
was not impaired by structured triglycerides or the physical mixture. The
interaction of the physical mixture with immune cells differed quite strongly from
that of structured triglycerides and long-chain triglycerides, with respect to
chemiluminescence. Studies on the clinical relevance of these immunologic
observations are needed.   
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Chapter 1
AIM OF THE THESIS
Total parenteral nutrition is nutrition composed of all the essential nutritional
components: lipids, carbohydrates, amino acids, minerals, trace elements and
vitamins, and is administered intravenously to patients. This technique is used in
the treatment of patients with gastrointestinal diseases and, on a large scale, in the
treatment of post-operative patients and patients on Intensive Care Units, in case
the gastrointestinal tract is temporarily incapable of adequate food absorption. 
Moreover, home parenteral nutrition is administered to patients with longstanding
malabsorption or dysmotility of the small bowel. They depend on parenteral
nutrition for their intake of calories and nutrients. The most common cause of
malabsorption in this group is the short bowel syndrome after partial small bowel
resection, characterized by weight loss, dehydration and deficiencies of minerals,
trace elements and vitamins.  
The aim of this study was to investigate the clinical relevant properties of safety and
tolerance, and the effects on nitrogen balance and immunology, of a newly
synthesized parenteral lipid emulsion: structured triglycerides. Based on animal
experiments, we postulated a positive effect on nitrogen balance with a good
tolerance and without severe complications. A positive effect of lipid emulsions on
nitrogen balance suggests conservation of muscle mass and organ function,
especially important in patients, who are more or less in a catabolic state. A
modulating effect of lipid emulsions on immunological functions may have
implications for patients, who often have infections and immunological disorders
or undergo surgery. 
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Chapter 2
THE HISTORY OF LIPID EMULSIONS IN TOTAL 
PARENTERAL NUTRITION
First attempts to use the parenteral route of administration of nutrients
In 1628 William Harvey was the first to describe the general blood circulation (1).
This concept leads to studies on the effect of intravenous administration of liquids,
like wine and ale in dogs by Christopher Wren in 1665. Wren’s study demonstrated
that intravenously infused alcohol had the same effect as when alcohol was given
orally (2).
In 1712 William Courten was the first to administer native (non-emulsified) olive
oil intravenously to a dog. The dog died in severe respiratory distress, probably due
to fat embolism in the lungs (3). Because of these side effects, Menzel and Perco
infused relatively large amounts of fat subcutaneously into dogs and men in 1869,
without detrimental effects (4). However, subcutaneous infusions by Paul Frie-
drich proved later, around 1900, to be too painful and parenteral infusion of lipids
was temporarily discontinued (5).
Nevertheless, other solutions proved to be useful for intravenous treatment. During
the cholera epidemic in England, in 1831, Thomas Latta successfully rehydrated
patients with intravenously infused salt solution (6) and in 1873 Hodder treated
cholera patients with intravenously infused fresh cow's milk with good result (7). 
Carbohydrates and proteins
Development of parenteral nutrition continued in the field of carbohydrates and
proteins. In 1859 Claude Bernard infused sugar solutions intravenously into
animals (8) and in 1896 Biedl and Kraus were the first to administer 10 % glucose
solutions intravenously to men (9). Research on carbohydrate infusion in man was
continued by Woodyatt et al. in 1915. Glucose proved to be the most efficient
carbohydrate and could be infused in doses up to 0.85 g of glucose/kg body
weight/hour without glucosuria, an amount twice the normal energy requirement
(10).  
At the beginning of the twentieth century the importance of proteins for
metabolism was understood. However, the first intravenous infusions of proteins
caused serious allergic reactions. In 1906 Abderhalden and Rona administered a
casein hydrolysate rectally to a boy and reported nitrogen equilibrium (11). And in
1913 Henriques and Andersen were the first to infuse a hydrolysate of beef into a
goat, resulting in a positive nitrogen balance (12). But it lasted until 1937, when
Robert Elman, known as "the father of intravenous nutrition", successfully infused
protein hydrolysates intravenously into men (13).
Although, since the discoveries of Lister and Pasteur, bacteria-free solutions were
used, infusions were often accompanied by fever. It lasted until the 1940's when it
was discovered that this fever was caused by pyrogens and that pyrogen-free
solutions should be administered. Pyrogens, consisting of endotoxins from
bacteria, were already discovered in 1923 by Siebert (14).
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The starting point of a wide-spread use of parenteral nutrition was the clinical
introduction of the central venous catheter by Stanley Dudrick (1968), which made
it possible to infuse large amounts of hypertonic glucose and protein hydrolysates
into men (15). In the United States, parenteral nutrition consisted for a long time of
only carbohydrates and amino acids; governmental permission for the use of lipid
emulsions was not given for fear of possible toxic effects. But long-term use of
glucose as the main energy source had disadvantages compared to a combination
with lipid. Longterm use of glucose alone resulted in essential fatty acid deficiency
characterized by growth retardation, poor wound healing, sparse hair growth and
dry flaky skin or even scaling eczematoid dermatosis. Moreover, large glucose
infusions resulted in hyperglycemia, hyperinsulinemia, increased secretion of ca-
techolamines, hepatic steatosis, and increased formation of carbon dioxide resulting
in respiratory problems (16,17,18). 
Parenteral long-chain triglyceride emulsions and new lipid emulsions
Until the 1960's experimental intravenous lipid emulsions caused adverse reactions,
like nausea, vomiting, back pain, fever and liver function disorders. By trial and
error, Schuberth and Wretlind, produced in 1961 a safe intravenous lipid emulsion
of soybean oil with egg yolk phospholipids as emulsifier (19,20). This soybean oil
emulsion contains triglycerides with only long-chain fatty acids attached to the
glycerol backbone and has a high content of essential fatty acids.
Efforts were made to further optimize this lipid emulsion. Research in animals
revealed that medium-chain triglycerides have metabolic benefits compared with
long-chain triglycerides (see Chapter 3). But long-chain triglycerides contain the
essential fatty acids, needed to prevent essential fatty acid deficiency. Therefore, in
the 1980's physical mixtures of both medium-chain triglycerides and long-chain
triglycerides were introduced. 
However, intravenously infused medium-chain triglycerides are metabolized to
medium-chain free fatty acids, which may be toxic in higher dose (see Chapter 3).
To further improve the safety of the use of medium-chain fatty acids, structured
triglycerides were synthesized. Structured triglycerides consist of triglycerides,
where the medium-chain and long-chain fatty acids are attached randomly to the
same glycerol backbone. Structured triglycerides are the subject of this thesis. 
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Chapter 3
STRUCTURED TRIGLYCERIDES
Joanna W. Kruimel, MD1
Ton H.J. Naber, MD, PhD1
1From the Department of Gastroenterology and Hepatology, University Medical
Center Nijmegen, Nijmegen, The Netherlands
Introduction
In 1961 Schuberth and Wretlind were the first to produce, by trial and error, a safe
intravenous lipid emulsion of soybean oil with egg yolk phospholipids as emulsifier
(1). This lipid emulsion contains triglycerides with only long-chain fatty acids
(LCFA) attached to the glycerol backbone (Fig. 1, LCT). 
In the 1980’s an emulsion with a combination of medium-chain triglycerides 
(Fig. 1, MCT) and long-chain triglycerides was introduced. Intravenously
administered triglycerides are hydrolyzed by lipoprotein lipase to free fatty acids and
glycerol or monoglycerides. Free fatty acids are taken up by the cells and oxidized in
the mitochondria. The uptake of long-chain fatty acids in the mitochondria is
carnitine-dependent, but the uptake of medium-chain fatty acids does not require
carnitine. This is important because carnitine levels are decreased in critically ill
patients, making medium-chain free fatty acids (MCFA) a rapidly accessible energy
source for these patients. Medium-chain fatty acids are taken up faster by the
mitochondria and are oxidized faster compared with long-chain fatty acids.
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Figure 1. The molecular structure of long-chain triglycerides (LCT), structured
triglycerides, and medium-chain triglycerides (MCT). A physical mixture of
medium-chain and long-chain triglycerides consists of triglycerides that contain
either three medium-chain fatty acids (MCFA) or three long-chain fatty acids
(LCFA). A structured triglyceride emulsion consists of triglycerides where the
medium- and long-chain fatty acids are randomly attached to the same glycerol
molecule.
Medium-chain triglycerides 
High plasma levels of medium-chain free fatty acids, the metabolic product of
medium-chain triglycerides, may cause adverse reactions, such as metabolic
acidosis due to higher production of ketone bodies (2) and increased energy
expenditure (3). In dogs, high plasma medium-chain free fatty acid levels, in
conjunction with high lactate and ketone body concentrations cause serious
neurological toxicity (4).
However, previous studies with physical mixtures of medium-chain and long-chain
triglycerides suggested that medium-chain triglycerides have metabolic benefits
compared with long-chain triglycerides, especially in animals. In humans nitrogen
balance improved in 5 out of 9 reported clinical trials comparing physical mixtures
with long-chain triglyceride emulsions (5-9); in the other 4 trials no significant
difference was found (10-13) (Table I). Medium-chain triglycerides are metabolized
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Table I. Summary of the published controlled clinical trials on nitrogen balance with
a physical mixture of medium-chain and long-chain triglycerides (MCT/LCT)
versus long-chain triglycerides (LCT).
MCT/LCT vs. LCT Patients, number Effect
Lai pediatric surgical significant better nitrogen 
38 balance from day 3, 14 days
Jiang surgical patients trend toward better 
12 nitrogen balance, 7 days
Ball critically ill significant better nitrogen 
20 balance on 6th and 9th day
Dennison likely to require TPN for significant better nitrogen
a minimum of 10 days balance cross-over, 
15 2 x 5 days
Lünstedt after elective colon surgery significant better nitrogen   
20 balance, 5 days
Nijveldt critically ill surgical no difference in nitrogen
20 balance, 5 days
Herrmann after colorectal surgery no difference in protein
29 balance
Ball malnourished patients no difference in daily nitrogen
24 balance, 6 - 28 days
Calon head trauma no difference in nitrogen
24 balance, 1 day
more rapidly and stored less in tissues (14). This may be explained by the
observation that their uptake by the mitochondria, where oxidation takes place, is
mainly independent of carnitine (14). 
In the physical mixtures of medium-chain triglycerides (MCT) and long-chain
triglycerides (LCT), triglyceride molecules contain three medium-chain fatty acids
or three long-chain fatty acids, attached to one glycerol molecule (Fig. 1). 
Structured  triglycerides
Structured triglycerides were synthesized to improve lipid emulsions by combining
medium-chain and long-chain fatty acids in one triglyceride molecule. The newly
synthesized structured triglycerides consist of triglycerides where the medium- and
long-chain fatty acids are randomly attached to the same glycerol backbone (Fig. 1).
In catabolic animals, parenteral administration of emulsions of structured
triglycerides, led to improved nitrogen balance (15,16,17), increased hepatic protein
synthesis (16,17) and serum albumin levels (16), and decreased leucine oxidation
(15,17), compared with emulsions of a physical mixture of medium- and long-chain
triglycerides.
Safety and tolerance
In 1993 Sandström et al. were the first to show that structured triglycerides
(Structolipid R, Pharmacia, now Fresenius-Kabi) are as safe and well-tolerated as a
conventional long-chain triglyceride emulsion (IntralipidR, Fresenius-Kabi) in post-
operative patients; in particular there were no signs of keto-acidosis or central
nervous system toxicity (18). 
Nitrogen balance  
The question has been put if structured triglyceride emulsions further improve
nitrogen balance compared with physical mixtures of medium-chain and long-
chain triglycerides in humans.
In recently published studies in patients, parenteral administration of emulsions of
structured triglycerides led to improved nitrogen balance compared with long-
chain triglyceride emulsions (19,20).
When we performed our clinical trial in post-operative patients treated with
structured triglycerides or with a physical mixture (see Chapter 5), no data were
available on nitrogen balance in patients comparing these two lipid emulsions. 
Serum triglycerides
In a second study in post-operative patients, Sandström et al. (21) demonstrated
lower serum triglyceride levels of structured triglycerides compared with long-
chain triglycerides leading to a reduced risk of fat overload. Whole body lipid
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oxidation rate of structured triglycerides was increased, suggesting higher
utilization of the structured triglycerides. Nordenström et al. (22) showed in
healthy volunteers reduced levels of serum triglycerides with structured
triglycerides compared with long-chain triglycerides.
No data were available on serum triglyceride levels in patients on structured
triglycerides compared with a physical mixture of medium-chain and long-chain
triglycerides, when we conducted our clinical trial in post-operative patients with
these two lipid emulsions (see Chapter 5) .
Plasma medium-chain free fatty acid levels
A study with structured triglycerides in healthy volunteers showed lower plasma
levels of medium-chain free fatty acids and the structured triglycerides were cleared
faster from the blood compared with a physical mixture (23,24).
No data were available on plasma levels of medium-chain free fatty acids in patients
on structured triglycerides compared with a physical mixture of medium-chain and
long-chain triglycerides, during the work on our clinical trial with these two lipid
emulsions (see Chapter 5).
Clinical trial
A clinical trial was designed to compare the nitrogen balance in post-operative
patients treated with structured triglycerides or with a physical mixture of medium-
and long-chain triglycerides. At the same time, serum levels of triglycerides and
plasma levels of medium-chain free fatty acids were measured during infusion of
the structured triglycerides to get more insight in clearance of medium-chain free
fatty acids. 
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Chapter 4
INTRAVENOUS LIPID EMULSIONS AND LEUKOCYTE FUNCTION:
A REVIEW
Joanna W. Kruimel, MD1
Ton H.J. Naber, MD, PhD1
1From the Department of Gastroenterology and Hepatology,
University Medical Center Nijmegen, Nijmegen, The Netherlands
Introduction
Since their introduction in clinical practice, the possible effects of lipid emulsions
on the function of the human immune system have remained the subject of debate.
In a large study of 395 malnourished patients requiring laparotomy or noncardiac
thoracotomy, more infectious complications were seen in the group receiving peri-
operative total parenteral nutrition including long-chain triglycerides compared
with the control group receiving no peri-operative parenteral nutrition (1). These
infections mainly comprised pneumonia or empyema and were not central venous
catheter related. The increased rate of infections was confined to borderline or
mildly malnourished patients. Severely malnourished patients who received peri-
operative parenteral nutrition had fewer non-infectious complications and no
increased rate of infectious complications compared with controls. The authors
concluded that peri-operative parenteral nutrition should be limited to a selected
group of severely malnourished patients. According to this study a possible
explanation for the increased rate of infections in the parenteral nutrition group is
the effect of  the lipid component of parenteral nutrition on leukocyte function. 
Lipid emulsions with long-chain triglycerides have been reported to impair
leukocyte function (2). Long-chain triglycerides may have a direct effect on
leukocytes, but also supply the essential fatty acids. The essential fatty acids are two
groups of polyunsaturated fatty acids, ω-3 and ω-6 fatty acids, which cannot be
manufactured by human metabolic pathways. They are precursors for inducers of
inflammation or immune suppression (prostaglandins, prostacyclins,
thromboxanes, leukotrienes) (3). In contrast, the use of lipid emulsions indirectly
can also have a beneficial effect on host defence. Lipid emulsions decrease the
amount of carbohydrate solutions needed to provide non-protein energy, resulting
in a reduced risk of hyperglycemia. Hyperglycemia in itself can increase the
susceptibility to infections (4).
Neutrophil functions
When an acute inflammatory reaction starts, leukocytes (firstly polymorpho-
nuclear leukocytes and later monocytes) are attracted to the site by chemotactic
agents, in a process called chemotaxis. In in-vitro experiments complement C5a,
activated serum and fMLP (formylated bacterial peptide) are the most common
chemotactic agents used. In contrast, random migration is the motility of
leukocytes in the absence of chemotactic agents.  
The next step in the inflammatory response is phagocytosis: ingestion of bacteria by
leukocytes. This function of cells can be studied in in-vitro experiments by the use
of fluorescent polystyrene microspheres, fluorescent yeast particles or bacteria. In-
vivo, clearance of bacteria or of radioactively labeled Tc-Sulfur colloid from the
blood stream is used to measure the efficiency of phagocytosis.
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Using bacteria, bacterial killing by the leukocytes can be measured. Production of
oxygen radicals is necessary for adequate bacterial killing. Oxygen radical
production can be measured in assays using chemiluminescence or reduction of
nitroblue tetrazolium (NBT).
Random migration
Wiernik et al. (5) found that in-vitro incubation of polymorphonuclear leukocytes
(PMN's) with Intralipid 20% (20-100 mg/mL) decreased random migration.
Incubation of monocytes with Intralipid did not have an effect on random
migration. Nordenström et al. (6) could not show a change in random migration of
leukocytes after in-vitro incubation with Intralipid 20% in a triglyceride
concentration up to 11,5 mmol/L. But in this study also healthy volunteers were
infused with Intralipid 20% for 2 hours at a rate of 50 mL/h, 100 mL/h and 200
mL/h; during infusion the leukocytes showed an impairment of random migration
and a correlation was obtained between the dose rate and the effect on random
migration. Twenty-two hours after infusion the effect on random migration had
disappeared. Herson et al. (7) could not find an effect of Intralipid up to 100 mg/mL
on neonatal PMN's in-vitro. In-vivo, Intralipid was infused at 1 g/kg over 16 hours
to ill neonates; no effect on random migration of PMN's was reported. Kohelet et
al. (8) and Bellatini-Pires (9) reported no changes in random migration of PMN's,
after in-vitro incubation with long-chain triglycerides. In the last study random
migration was decreased, after incubation with a physical mixture of medium- and
long-chain triglycerides (9). Usmani et al. (10) showed an increase in random
migration of PMN's of neonates after Intralipid infusion.
Chemotaxis 
Nordenström et al. (6) reported decreased chemotaxis of leukocytes after in-vitro
incubation with Intralipid 20% in a triglyceride concentration up to 11,5 mmol/L.
A linear correlation was observed between triglyceride concentration and
chemotaxis. The highest concentration of 11,5 mmol/L Intralipid triglyceride
inhibited chemotaxis by 40%. Their infusion studies in healthy volunteers showed
decreased leukocyte chemotaxis at dose rates of 50 mL/h to 200 mL/h. Again a
correlation between dose rate and inhibition of chemotaxis was demonstrated.
Twenty-two hours after infusion the effect on chemotaxis had disappeared. Other
authors reported a decrease in chemotaxis of PMN's (5,8,11,12) after incubation
with LCT's. Only Palmblad et al. (13) found an increase in chemotaxis of PMN's
stimulated by serum of volunteers given 500 mL Intralipid 10% for six hours.
Wiernik et al. (5) reported an increase in chemotaxis of monocytes in-vitro
incubated with Intralipid 20 to 60 mg/mL. At higher concentrations, of 100
mg/mL, chemotaxis decreased again. Some studies could not find an effect of LCT's
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on chemotaxis of PMN's in-vitro (7,9,14,15) or in-vivo (7,14,16,17). Usmani et al.
showed an increase of chemotaxis of PMN's of neonates after in-vitro incubation
with Intralipid (15) and infusion of Intralipid (10). In one study of Bellatini-Pires
(9) chemotaxis was decreased, after incubation with a physical mixture of medium-
and long-chain triglycerides.
Phagocytosis and bacterial killing
Wiernik et al. (5) tested the attachment and ingestion of fluorescein labeled yeast
particles by leukocytes. After incubation with Intralipid 20% up to 100 mg/mL
monocytes in suspension showed a decreased number of attached yeast particles per
cell but an increased number of ingested yeast particles per cell. In the same test
PMN's in suspension showed the opposite; the number of attached yeast particles
per cell was increased and the number of ingested yeast particles was decreased.
Bellatini-Pires (18) reported that in-vitro incubation of PMN's with Intralipid
reduced phagocytosis and bacterial killing. Jarstrand et al. (19) showed that
Intralipid reduced bacterial killing after infusion in patients and in-vitro. Ota et al.
(17) evaluated the effect of Intralipid on malnourished patients who received TPN
pre-operatively; they found no effect on phagocytosis and bacterial killing of
PMN's, using an assay with Staphylococcus aureus. Palmblad et al. (13) gave
Intralipid 10% 500 mL in 6 hours to volunteers and saw no effect on PMN bacterial
killing also using an assay with Staphylococcus aureus. 
Chemiluminescence
PMN's respond to various stimuli with a "metabolic burst" of oxygen radical
production, necessary for bacterial killing. By measuring chemiluminescence
oxygen radical production can be assessed. PMN's are incubated with a stimulant
(concanavalin A for nonphagocytic stimulation and opsonized Zymosan for
phagocytic stimulation) and Luminol, which produces light emission in the
presence of oxygen radicals. The samples are then counted in a scintillation
spectrophotometer.
In the experiments of Palmblad et al. (13) an increase in chemiluminescence of PMN's
of healthy volunteers was observed after intravenous infusion of long-chain
triglyceride emulsions. In the study of Robin (20), pre-incubation of whole blood
from healthy volunteers with Intralipid up to a triglyceride concentration of 400
mg/L did not adversely influence chemiluminescence. However when chronically ill
patients were given 500 mL Intralipid in 4 to 6 hours chemiluminescence of PMN's
was decreased. Jarstrand et al. (21) showed that in-vitro incubation of PMN's with
Intralipid decreased chemiluminescence. Usmani et al. showed that in-vitro
incubation of PMN's of neonates with Intralipid had no effect on chemiluminescence
(15); after infusion of Intralipid in neonates, chemiluminescence was increased (10). 
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Nitroblue tetrazolium activity
The nitroblue tetrazolium (NBT) test determines the ability of PMN's to generate
superoxide, necessary for bacterial killing, by measuring the reduction of NBT.
Ingesting phagocytes convert the yellow soluble dye to an insoluble dark blue
precipitate in the phagocytic vacuole.
Wiernik et al. (5) reported a significant decrease in NBT activity of PMN's in vitro
after incubation with Intralipid 20% 20 mg/mL to 100 mg/mL; the NBT reduction
of monocytes did not change significantly in the in-vitro incubation experiments.
However the infusion experiments in healthy volunteers (20% Intralipid for 2
hours at a rate of 100 mL/h) showed that the NBT reduction of monocytes "at rest"
as well as on stimulation with E. coli increased significantly. Jarstrand et al. showed
that Intralipid decreased NBT reduction after infusion in patients (19) and in-vitro
(19,21). Bellatini-Pires reported that in-vitro incubation of PMN's with Intralipid
did not effect NBT reduction, but incubation with a physical mixture decreased
NBT reduction (18). Strunk et al. (22) did not find a change in NBT reduction of
peritoneal macrophages from mice treated with Intralipid 5 mg/kg up to two
weeks.
In-vivo clearance of bacteria and Technetium-sulfur colloid
Fisher et al. (11) found an impairment of bacterial clearance (group B streptococcus)
in mice given intraperitoneal injections of Intralipid. Sobrado et al. (23) found that
the capacity of bacterial clearance (Pseudomonas aeruginosa P4) in healthy and
burned guinea pigs was unaffected by the quantity of lipids administered
intravenously and the type of lipid emulsion (long-chain triglycerides, medium-
chain triglycerides, structured triglycerides) given. But when 75% or more of the
non-protein calories was given as long-chain triglycerides to burned guinea pigs
(which is not a physiological dose), a different pattern of bacterial clearance was
observed compared to the guinea pigs given less of their non-protein calories as
long-chain triglycerides. The sequestration of bacteria was reduced in liver and
spleen and markedly increased in the lungs. When medium-chain triglycerides or
structured triglycerides were given in the same dose, this change in pattern of
bacterial clearance was not seen. These data were confirmed by Hamawy et al. (24),
who showed that rats treated with medium-chain triglycerides were not bacteremic,
three days following a septic injury in contrast to the animals treated with long-
chain triglycerides. Moreover the medium-chain triglyceride-treated animals
sequestered more bacteria in the liver and less in the lung compared to the long-
chain triglyceride-treated animals. 
Seidner et al. (25) and Jensen et al. (26) studied the effects of  total parenteral
nutrition (TPN) with long-chain triglycerides in patients at 0,13 g/kg/h over 10
hours for each of 3 days; there was a significant decline in Technetium-sulfur col-
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loid (TSC) clearance rate by the mononuclear phagocyte system. This dose of  lipid
emulsion is rather high. In contrast, in patients given long-chain triglycerides as a
continuous infusion or in patients given a physical mixture of medium-chain and
long-chain triglycerides intermittently this decline was not seen (26).
Recent developments
In recent years a number of experimental studies have been published, which
suggest that lipid structure, and especially carbonchain-length, is of pivotal
importance in the interaction of nutritional triglycerides and the various
components of the immune system (27). Earlier studies on the effect of lipids on
immune function in PMN’s are included in this thesis and successively Wanten has
continued these studies. Briefly, the effects of emulsions containing medium-chain
triglycerides markedly contrast with those of emulsions containing long-chain
triglycerides, structured triglycerides, or emulsions based on olive- or fishoil. For
instance, it was found that the production of toxic oxygen radicals by human
PMN’s is induced by medium-chain triglycerides in the absence of any other
stimulus, while long-chain triglycerides and structured triglycerides completely
lack such effects (28). Also, the expression of cell surface adhesion molecules as well
as neutrophil degranulation, which indicate cell activation, are induced by medium-
chain triglycerides, but not by long-chain triglycerides or structured triglycerides
(29). These observations were done at clinically relevant lipid concentrations well
below 5 mmol/L. 
That this activation by medium-chain triglycerides might well be an ‘inappropriate’
stimulus is suggested by the observation that medium-chain triglycerides, but not
long-chain triglycerides or structured triglycerides, impair neutrophil locomotion
and killing of the fungal pathogen Candida albicans (30,31). These in-vitro data
have been corroborated by a study in human healthy volunteers in which
intravenous administration of  a physical mixture of medium- and long-chain
triglycerides, but not long-chain triglycerides or placebo (saline), modulated the
production of cytokines by mononuclear cells in a manner that suggests the
introduction of an imbalance between various populations of T helper-cell
lymphocytes. Such disturbances of the immune response have been implicated in
the development of fungal infections. Further evidence for an increased risk of
fungal infections was found, when the growth of Candida was shown to be
increased in serum of patients after physical mixture administration, while long-
chain triglycerides and placebo did not display any effect.
Possible mechanisms behind these effects of medium-chain triglycerides include
alterations in membrane fluidity and effects on calcium-mediated cell signaling
(32,33,34). Membrane fluidity is a complex feature of biological membranes that
refers to the degree of freedom of molecules in the outer cell membrane, which has
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implications for the function of cell surface receptors. It was found that medium-
chain triglycerides, but not long-chain triglycerides increase neutrophil membrane
fluidity, while medium-chain fatty acid-containing structured triglycerides display
an intermediate effect. Also, it was found that medium-chain triglycerides, but not
long-chain triglycerides or structured triglycerides, influence the kinetics of the
release of calcium from intracellular stores in PMN’s in response to stimulation by
opsonized yeast particles (serum-treated Zymosan) or the bacterial peptide fMLP. 
Conclusion
The effect of intravenous administration of the three types of lipid emulsions on
leukocyte function is still controversial. In-vitro studies concern mostly long-chain
triglyceride emulsions and in general demonstrated inhibition of leukocyte
function. Random migration (5), chemotaxis (5,6,8,11,12), phagocytosis (5,18),
bacterial killing (18,19) and production of oxygen radicals (5,18,19,21) by PMN’s
was impaired by long-chain triglycerides. However, other studies could not find
any impairment in PMN function by incubation with long-chain triglycerides
(7,9,10,13-15,20). In-vitro, a physical mixture of medium- and long-chain
triglycerides inhibited chemotaxis (9), random migration (9), phagocytosis (18) and
bacterial killing (18); more studies on physical mixtures are necessary.
The results of infusion studies in volunteers and patients are contradictory and also
mainly concern long-chain triglyceride emulsions. Nordenström et al. (6) found a
dose rate dependent impairment of random migration and chemotaxis of PMN’s by
long-chain triglycerides in volunteers. Jarstrand et al. (19) and Robin et al. (20)
reported a suppression of production of oxygen radicals by long-chain
triglycerides, in the first study accompanied by a reduced bacterial killing (19).
Other human infusion studies were not able to confirm suppression of PMN
function by long-chain triglycerides (10,13,17). One study in volunteers during
infusion of a physical mixture of medium- and long-chain triglycerides did not
show any impairment of chemotaxis, adherence and phagocytosis by PMN’s (35).
TPN, with long-chain triglycerides intermittently given, caused a decline in
phagocytotic capacity in patients (25,26); TPN, with a physical mixture of medium-
and long-chain triglycerides intermittently given, caused no decline in phagocytotic
capacity (26). 
Wanten et al. found that the effects of emulsions containing medium-chain
triglycerides markedly contrast with those of emulsions containing long-chain
triglycerides or structured triglycerides: the production of toxic oxygen radicals by
human PMN’s was induced by medium-chain triglycerides in the absence of any
other stimulus, and the expression of cell surface adhesion molecules as well as
neutrophil degranulation (which indicate cell activation) were induced by medium-
chain triglycerides, but not long-chain triglycerides or structured triglycerides (27).
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In conclusion, some in-vitro and in-vivo studies show impairment of leukocyte
function by long-chain triglyceride emulsions. Recent data from our group indicate
that the interaction of  medium-chain triglyceride emulsions with immune cells
differs quite strongly from that of emulsions containing long-chain triglycerides or
structured triglycerides. More studies on the effects of lipid emulsions on the
immune system are needed, especially studies on the clinical relevance of the
observations mentioned above.
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Abstract
Background Most post-operative patients lose net protein mass, which reflects loss
of muscle tissue and organ function. Peri-operative parenteral nutrition may reduce
the loss of protein, but in general, with conventional lipid emulsions a waste of
protein still remains.
Methods We compared the effects on nitrogen balance of an emulsion containing
structured triglycerides, a new type of synthesized triglycerides, with an emulsion
of a physical mixture of medium- and long-chain triglycerides as part of parenteral
feeding in moderately catabolic patients. The first 5 days after placement of an
aortic prosthesis patients received total parenteral nutrition (TPN) providing 0.2 g
of nitrogen per kg body weight per day; energy requirement was calculated using
Harris and Benedict's equation, adding 300 kcal per day for activity. Twelve patients
were treated with the structured triglyceride emulsion and 13 patients with the
emulsion of the physical mixture of medium- and long-chain triglycerides. The
design was a randomized, double-blind parallel study. 
Results In the patients who completed the study, the mean cumulative nitrogen
balance over the first 5 post-operative days was -8 ± 2 g in 10 patients on the
structured triglyceride emulsion and -21 ± 4 g in 9 patients on the emulsion of the
physical mixture of medium- and long-chain triglycerides; the mean difference was
13 g of nitrogen (95 % confidence interval 4 to 22, p = .015) in favor of the
structured triglyceride emulsion. On the first post-operative day serum triglyceride
and plasma medium-chain free fatty acid levels increased less during infusion of the
structured triglyceride emulsion than with the physical mixture emulsion.
Conclusions The parenteral structured triglyceride emulsion improves the nitrogen
balance and is cleared faster from the blood, compared with the emulsion of the
physical mixture of medium- and long-chain triglycerides, in moderately catabolic
patients.
Introduction
After major surgery, most patients become catabolic and lose net protein mass,
resulting in loss of muscle tissue and organ function. Improvement of protein
retention is important for conservation of muscle mass and organ function. Peri-
operative parenteral nutrition may reduce the loss of protein (1) and improve
outcome in severely malnourished patients (2,3), but with existing regimes a
considerable waste of protein still remains.
Lipid emulsions are an important component of total parenteral nutrition (TPN).
They supply energy and essential fatty acids. Soybean oil is the usual source of fat
in parenteral fat emulsions and consists of long-chain triglycerides. Medium-chain
triglycerides have been suggested as an alternative lipid source, because they
improve nitrogen balance (4,5), are metabolized more rapidly and stored less in
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tissues (6), and are oxidized mainly independently of carnitine (6). However, high
plasma levels of medium-chain free fatty acids, the metabolic product of medium-
chain triglycerides, may cause adverse reactions, such as metabolic acidosis due to
higher production of ketone bodies (7) and increased energy expenditure (8). In
dogs, high plasma medium-chain free fatty acid levels caused serious neurological
toxicity (9). To reduce the amount of medium-chain triglycerides and to provide the
essential long-chain fatty acids, the medium-chain triglycerides are administered
together with long-chain triglycerides, as a physical mixture.
To improve the safety of medium-chain triglycerides, so-called structured
triglycerides were synthesized. Structured triglycerides are produced by hydrolysis
of soybean oil and coconut oil. Reesterification results in structured triglycerides
with medium- and long-chain fatty acids at random attached to positions within the
same glycerol molecule. An emulsion containing these structured triglycerides
caused lower plasma levels of medium-chain free fatty acids and was cleared faster
from the blood compared with an emulsion of a physical mixture of medium-chain
and long-chain triglycerides, in healthy volunteers (10,11).
The question has been asked if this structured triglyceride emulsion improves
nitrogen balance. In animals, parenteral administration of emulsions of structured
triglycerides leads to improved nitrogen balance (12-14), increased hepatic protein
synthesis (13,14) and serum albumin levels (13), and decreased leucine oxidation
(12,14) compared with emulsions of a physical mixture of medium- and long-chain
triglycerides.
The predefined objectives of the present clinical trial were to study, in post-
operative, moderately catabolic patients, the influence on nitrogen balance and the
safety and tolerance of intravenous (IV)-infused structured triglycerides
(Structolipid) compared with that of a physical mixture of medium- and long-chain
triglycerides (Lipofundin MCT/LCT 20%). The structured triglyceride emulsion
has been compared with an emulsion of long-chain triglycerides, proven to be as
safe and well tolerated (15), and associated with increased whole body fat oxidation
in post-operative patients (16).
Materials and methods
Design
The design was a randomized, double-blind, parallel study. We excluded some
important confounders. We chose for a homogeneous and stable group of patients
(only elective surgery), and enteral nutrition was not permitted until the end of the
study period. We included patients operated for placement of an aortic tube or
bifurcation prosthesis because of an abdominal aortic aneurysm or atherosclerotic
obstruction. Such patients make a homogeneous group, are moderately catabolic
(17), and may require post-operative parenteral nutrition. We chose to administer
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parenteral nutrition in all of these patients, although in clinical practice not all of
these patients would need parenteral nutrition. Probably in some patients
nutritional needs could be reached by tube feeding in the duodenum or jejunum. 
We calculated the daily cumulative nitrogen balance for those patients who
completed the 5-day study period. We assessed safety and tolerance in accordance
with standard clinical practice. Serum levels of triglycerides and plasma levels of
medium-chain free fatty acids were measured as an estimate of the clearance rate of
the lipid emulsions from the blood. IV-administered triglycerides are hydrolyzed
by lipoprotein lipase, producing long-chain and medium-chain free fatty acids.
Patients
The study was approved by the Human Ethics Committee of the University
Hospital of Nijmegen, The Netherlands. Over a period of 20 months, 61 patients
were admitted to the Department of Surgery for elective surgery. Placement of an
aortic tube or bifurcation prosthesis, because of an abdominal aortic aneurysm or
atherosclerotic obstruction was performed. Thirty-four patients were excluded
because of either hypertriglyceridemia (9), treatment with lipid lowering-drugs (8),
not giving written consent (7), treatment with corticosteroid hormones (5), renal
disease (3), diabetes mellitus (2), age above 80 years (1), severe overweight (1), or
fluid restriction (1). Three patients fulfilled two exclusion criteria. 
Twenty-seven patients were informed by verbal and written consent, after which
they were randomized. In none of the patients was significant weight loss observed
before the hospitalization. Pre-operatively the patients were normally active. In all
of these patients elective surgery was performed. Two patients dropped out before
treatment started: 1 changed her decision to participate, and 1 suffered a myocardial
infarction after inclusion in the study. We used a table with random numbers to
assign patients to receive either the structured triglyceride emulsion (n = 12) or the
emulsion of the physical mixture of medium- and long-chain triglycerides (n = 13).
Four patients were withdrawn after treatment had started for reasons not related to
the lipid emulsions: Adult Respiratory Distress Syndrome, aspiration of stomach
contents, ventricular fibrillation, and thrombosis in the subclavian vein.
Post-operatively these patients were not on a respiratory ventilator during the
nitrogen balance study, and patients were mobilized as soon as possible. After 5
days, when the study was completed, oral intake was started if possible.
Before nitrogen excretion was measured, and still blinded to treatment, one patient
was excluded from calculation of the nitrogen balance. He was treated with the
physical mixture. The reason for exclusion of this patient was extensive muscle
breakdown due to muscle ischemia and compression, which is known to produce
high nitrogen excretion. In one patient treated with the structured triglyceride, day
4 urine was lost. This patient was also excluded from calculation of the nitrogen
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balance. Therefore nitrogen balance was calculated for 10 patients treated with the
structured triglyceride emulsion and for 9 patients treated with the emulsion of the
physical mixture who completed the 5-day study period.
Treatment
In all patients parenteral nutrition was started with an administration rate according
to nutritional need. Patients were treated with a structured triglyceride emulsion
(Structolipid, Fresenius-Kabi, Sweden) or an emulsion of a physical mixture of
medium- and long-chain triglycerides (Lipofundin MCT/LCT 20%, B. Braun
Melsungen AG, Germany) (Table I). Figure 1 shows the molecular structure of
MCT, LCT, and structured triglycerides. Structured triglycerides are produced by
hydrolysis of MCT and LCT in glycerol and free fatty acids and subsequent at
random re-esterification of glycerol with free fatty acids. 1,3-specific lipase is not
used. Both patient groups received an equal dose of lipid emulsion in weight with
equal energy content, because we chose to compare the emulsions under
energetically equivalent conditions. The patients, treated with the physical mixture-
emulsion, received 1.08 times more triglycerides and 1.25 times more medium-
chain fatty acids, both on a molar base.
29
Figure. 1. The molecular structure of long-chain triglycerides, structured
triglycerides, and medium-chain triglycerides.
The patients were treated with TPN for the first 5 days after surgery. We calculated
energy requirement in kcal/24 h using Harris and Benedict's equation [males: 66.47
+ 13.75 x weight (kg) + 5.0 x height (cm) - 6.76 x age (years); females: 655.10 + 9.56
x weight (kg) + 1.85 x height (cm) - 4.68 x age (years)] and added 300 kcal/24 h for
activity. We gave 0.2 g of nitrogen/kg body weight per 24 h (Vamin 18, Fresenius-
Kabi, Sweden), which is in accordance to the nutritional needs of  this group of
patients (18). Two-thirds of the non-protein energy or 53 % of total energy was
given as carbohydrates (glucose 40%), one-third of the non-protein energy or 26 %
of total energy as lipid emulsion, and 21% of total energy as amino acids. Amino
acids and carbohydrates were given daily over 24 hours, throughout the 5-day post-
operative period. The lipid emulsions were administered separately, because
stability studies of mixtures of the structured triglyceride emulsion, and amino
acids and carbohydrates were not available. The lipid emulsions were administered
daily from 10 AM to 4 PM, because lipids could disturb the laboratory assessments
and baseline blood samples were taken at 8 AM. This intermittent administration of
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Table I. Composition and characteristics of the structured triglyceride emulsion and
of the emulsion of the physical mixture of medium- and long-chain triglycerides
Composition and characteristics Structured Physical
triglyceride mixture
emulsion emulsion
Structured triglycerides (g/L) 200
Soy bean oil (g/L) 100
Medium-chain triglycerides (g/L) 100
Mean molecular weight of
triglycerides 683 634
Fractionated egg phospholipids (g/L) 12 12
Glycerol (USP) (g/L) 22.5 25.0
Water for injection ad (mL) 1000 1000
pH 8 6.5-8.5
Osmolality (mOsm/kg water) 350 380
Energy content (kcal/L) 1960 1936
Fatty acid composition, % by weight
Caprylic acid (C8:0) 27 26
Capric acid (C10:0) 10 20
Palmitic acid (C16:0) 7 7
Stearic acid (C18:0) 3 2.5
Oleic acid (C18:1) 13 13
Linoleic acid (C18:2ω6) 33 27
Alpha-linolenic acid (C18:3ω3) 5 3.5
Other 2 1
lipid emulsions allowed us to study the kinetics of the lipid emulsions. All
parenteral nutrition was administered through one lumen of a double-lumen
subclavian catheter. IV medication was given separately through the other lumen of
the subclavian catheter or via a peripheral catheter. Amino acids, carbohydrates and
lipid emulsion were given at constant rates using 3 separate infusion pumps
(Terufusion STC-503, Terumo, The Netherlands). Oral intake of nutrients was not
allowed during the study period.
Assessments
The following baseline characteristics of the patients were determined: sex, race,
age, nutritional status, duration of surgery, blood loss during surgery, and Acute
Physiology and Chronic Health Evaluation (APACHE) II score (19). Nutritional
status was assessed by measuring height and weight, and calculating body mass
index [weight per square height]. Furthermore, skinfold thickness according to
Durnin and Womersley (20) was measured at 4 sites (biceps, triceps, subscapular
and supra-iliac), giving the body fat content of the patient; the percentage of ideal
body fat content was calculated. Also, width of condyle of femur was measured
according to de Wijn (21), giving the ideal weight of the patient; the body weight
was measured and the percentage of ideal body weight was calculated.
Blood pressure, heart rate, respiratory frequency, body temperature, and adverse
events of each patient were monitored, each post-operative day at 8 AM and 4 PM.
The patients especially were monitored for infectious complications, allergic
reactions, nausea, chills and neurological symptoms. In addition, the APACHE II
score was evaluated on days 1, 3 and 6 at 8 AM.  
We calculated the nitrogen balance per 24 hours from the amounts of nitrogen
administered parenterally and the nitrogen excreted in the urine. We assumed a
daily loss of 2 g of nitrogen via other routes (18). During the first 5 days post-
operatively nitrogen was only provided by the parenteral nutrition because oral
intake of nutrients was not allowed. Under close supervision urine was collected
daily and pooled in 24-hour aliquots from 6 AM until 6 AM the following day, and
the urine was transported every morning to the laboratory at 8 AM. Urinary
nitrogen content was analyzed according to Kjeldahl (22).
Serum levels of triglycerides and plasma levels of medium-chain free fatty acids
were measured on the first and fifth day after surgery before and at the end of lipid
infusion, i.e. at 8 AM and 4 PM; one more sample was taken at the end of the study,
on the sixth day at 8 AM. Serum triglycerides were measured by the Böhringer
Mannheim Kit for triglyceride analysis without free glycerol. Plasma medium-
chain free fatty acids were analyzed according to Tsuchiya et al. (23). The free fatty
acids were separated by reversed-phase high-performance liquid chromatography
(HPLC) on a C18 column after a derivatization reaction with a fluorescent reagent,
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4-bromomethyl-7-acetoxycoumarin. The free fatty acid derivatives were detected
by fluorescence detection. 
Blood hemoglobin, white blood cell count with differential count and platelet
count, serum sodium, potassium, urea, creatinine, total bilirubin, alkaline
phosphatase, aspartate aminotransferase, glucose, and ß-hydroxybutyrate were
measured before surgery, at 8 AM on day 1 before the start of parenteral nutrition,
and at 8 AM on days 3 and 6. Bèta-hydroxybutyrate was determinated on a
centrifugal analyzer (Multistat III) (24).
Statistical analysis
The primary end point for comparison between the groups was the daily
cumulative nitrogen balance calculated for those patients who completed the 5-day
study period. Two secondary end points were tested: changes in serum levels of
triglycerides and changes in plasma levels of medium-chain free fatty acids. All
results were expressed as mean ± SEM. Changes in the structured triglyceride-
emulsion group were compared with changes in the physical mixture-emulsion
group, using Student's t test, and the 95 % confidence level was calculated.
Results
Baseline characteristics of the two groups were similar with respect to sex, race, age,
nutritional status, duration of surgery, and APACHE II score. After treatment had
started, 6 patients dropped out for calculation of the nitrogen balance over the first
5 days. Baseline characteristics of the 2 groups remained similar when these 6
patients were excluded. Blood loss during surgery was a little smaller in the
structured triglyceride-emulsion group (1420 ± 680 mL) than in the group treated
with the emulsion of the physical mixture of medium- and long-chain triglycerides
(2130 ± 880 mL] (Table II). The difference in blood loss did not influence the
nitrogen balance study, because the nitrogen balance started the day after surgery.
The mean cumulative nitrogen balance was calculated for those patients who
completed the 5-day study period. The mean cumulative nitrogen balances of the 2
study groups became significantly different on the fourth post-operative day: -5 ±
2 g of nitrogen for the 10 patients receiving the structured triglyceride emulsion and
-16 ± 4 g of nitrogen for the 9 patients receiving the emulsion of the physical
mixture of medium- and long-chain triglycerides. The mean difference in
cumulative nitrogen balance over the 4 day-period was 11 grams of nitrogen (95 %
confidence interval 2 to 19, p = .02). After 5 days the mean cumulative nitrogen
balance was -8 ± 2 g for the structured triglyceride emulsion and -21 ± 4 g for the
emulsion of the physical mixture; the nitrogen balance was thus 13 g less negative
for the structured triglyceride emulsion than for the emulsion of the physical
mixture (95 % confidence interval 4 to 22, p = .015) (Table III, Fig. 2a and 2b).
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Table II. Baseline characteristics of patients treated with the structured triglyceride
emulsion or with the physical mixture emulsion
Baseline characteristics Structured triglyceride Physical mixture
emulsion emulsion
Men/women (number) 10/2 10/3
Caucasian/noncaucasian (number) 12/0 12/1
Age (years) 67 ± 6 69 ± 7
Height (m) 1.68 ± 0.09 1.66 ± 0.09
Weight (kg) 73 ± 10 69 ± 13
Body Mass Index (kg/m2)  26 ± 3 25 ± 3
% of ideal body fat content 106 ± 5 105 ± 5
% of ideal body weight 108 ± 12 106 ± 9
Duration of surgery (min) 150 ± 70 160 ± 40
Blood loss during surgery (mL) 1420 ± 680 2130 ± 880
APACHE II score 7 ± 1 7 ± 1
Values are numbers or means ± SD.
Table III. Cumulative nitrogen balance over the first five days after surgery for 10
patients treated with the structured triglyceride emulsion and 9 patients treated with
the physical mixture emulsion, who completed the 5-day nitrogen balance
Structured triglyceride emulsion day 1 day 2 day 3 day 4 day 5
Nitrogen parenterally administered (g) +15±1 +30±1 +45±1 +60±2 +74±2
Urinary nitrogen excretion (g) -14±1 -30±2 -44±3 -57±3 -72±4 
Assumed nitrogen loss via other routes (g) - 2 - 4 - 6 - 8 -10
Cumulative nitrogen balance (g) - 1±1 - 4±1 - 5±2 - 5±2* - 8±2**
Physical mixture emulsion day 1 day 2 day 3 day 4 day 5
Nitrogen parenterally administered (g) +14±1 +27±2 +41±2 +55±3 +68±4
Urinary nitrogen excretion (g) -14±1 -31±3 -46±5 -63±6 -79±7
Assumed nitrogen loss via other routes (g) - 2 - 4 - 6 - 8 -10
Cumulative nitrogen balance (g) - 2±1 - 8±1 -11±3 -16±4* -21±4**
Values are means ± SEM.
* mean difference 11 g (95% confidence interval 2; 19, p = .02).
**mean difference 13 g (95% confidence interval 4; 22, p = .015). 
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Figure 2. (a) Daily nitrogen balances and (b) cumulative nitrogen balances over the
first five days after surgery for 10 patients treated with the structured triglyceride
emulsion (hatched bars) and 9 patients treated with the physical mixture emulsion
(solid bars), who completed the 5-day nitrogen balance.
a
b
On the first post-operative day, serum levels of triglycerides and plasma levels of
medium-chain free fatty acids increased less during the 6 hours of lipid infusion
with the structured triglyceride emulsion compared with the physical mixture of
medium- and long-chain triglycerides (the difference in change for triglycerides
between treatment with the structured triglyceride emulsion and the physical
mixture emulsion was 1.10 mmol/L, 95% confidence interval 0.70 to 1.50, p <
.00005, and for medium-chain free fatty acids 145 µmol/L, 95% confidence interval
99 to 161, p = .00001, Table IV). These differences were higher than expected from
the difference in emulsion composition on a molar base. Both groups received an
equal dose of lipid emulsion in weight; thus, the physical mixture-emulsion group
received 1.08 times more triglycerides and 1.25 times more medium-chain fatty
acids, both on a molar base. However, serum triglycerides and plasma medium-
chain free fatty acids concentrations increased 2 times more with the physical
mixture-emulsion group. On the fifth post-operative day after infusion of the lipid
emulsions, changes in serum triglycerides and plasma medium-chain free fatty acids
concentrations were, although lower in the group receiving the structured
triglyceride emulsion, not significantly different for the 2 patient groups
(triglycerides 0.27 mmol/L, 95% confidence interval -0.19 to 0.73; medium-chain
free fatty acids 70 µmol/L, 95% confidence interval 2 to 138, p =.07, Table V).
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Table IV. Changes in mean serum levels of triglycerides (mmol/L) and plasma levels
of medium-chain free fatty acids (MCFFA,µmol/L) on day 1 post-operatively, from
8 AM, before the start of the lipid infusion, until 4 PM, at the end of lipid infusion
Time Variables Structured Physical
triglyceride mixture
emulsion emulsion
Day 1, 8 AM triglycerides 0.86 ± 0.07 0.74 ± 0.07
MCFFA 12 ± 4 7 ± 3
Day 1, 4 PM triglycerides 1.44 ± 0.12   2.42 ± 0.16
MCFFA 149 ± 13 289 ± 18
Change day 1, triglycerides 0.58 ± 0.10 1.68 ± 0.17*
4 PM - 8 AM MCFFA 137 ± 14 282 ± 18 **
Values are means ± SEM. 
* On day 1 the difference in change between treatment with the structured triglyceride
emulsion and the physical mixture emulsion was for triglycerides 1.10 mmol/L, 95%
confidence interval 0.70 to 1.50, p < .00005.
** On day 1 the difference in change between treatment with the structured triglyceride
emulsion and the physical mixture emulsion was for medium-chain free fatty acids 145
µmol/L, 95% confidence interval 99 to 161, p = .00001.
Adverse events, especially infectious complications, blood pressure, heart rate,
respiratory frequency, body temperature, and APACHE II score did not show
significant differences between both groups. Blood hemoglobin, white blood cell
count with differential count and platelet count, serum sodium, potassium, urea,
creatinine, total bilirubin, alkaline phosphatase, aspartate aminotransferase, glucose
and ß-hydroxybutyrate were also similar in both groups at 8 AM on days 1, 3 and 6. 
Discussion
Nitrogen balance was measured to compare the efficacy of an emulsion containing
"structured" triglycerides - i.e. triglycerides having medium-chain and long-chain
fatty acids within the same molecule - and an emulsion of a physical mixture of
medium-chain and long-chain triglycerides. A less negative nitrogen balance
indicates conservation of protein mass, including muscle mass. Nitrogen balance
studies are widely used as an index of effectiveness of nutrition support (18); a
better index is not yet available (25). 
An emulsion of a physical mixture of medium- and long-chain triglycerides is
known to improve nitrogen balance in patients compared with long-chain
triglyceride emulsions (4,5). We found that parenteral administration of a "struc-
tured" triglyceride emulsion improved nitrogen balance in patients after a large
vascular operation compared with an emulsion of a physical mixture of medium-
and long-chain triglycerides. Daily urinary nitrogen excretion was higher in the
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Table V. Changes in mean serum levels of triglycerides (mmol/L) and plasma levels
of medium-chain free fatty acids (MCFFA,µmol/L) on day 5 post-operatively, from
8 AM, before the start of the lipid infusion, until 4 PM, at the end of lipid infusion
Time Variables Structured Physical
triglycerides mixture
emulsion emulsion
Day 5, 8 AM triglycerides 1.12 ± 0.20 1.10 ± 0.04
MCFFA 11 ± 3 4 ± 3
Day 5, 4 PM triglycerides 1.99 ± 0.24 2.24 ± 0.17
MCFFA 168 ± 25 231 ± 25
Change day 5, triglycerides 0.87 ± 0.17 1.14 ± 0.16 ns
4 PM - 8 AM MCFFA 157 ± 22 227 ± 26 ns
Values are means ± SEM.
nsOn day 5 the difference in change between treatment with the structured triglyceride
emulsion and the physical mixture emulsion was for triglycerides 0.27 mmol/L, 95%
confidence interval -0.19 to 0.73, not significant; and for medium-chain free fatty acids 70
µmol/L, 95% confidence interval 2 to 138, not significant (p = 0.07).
physical mixture-emulsion group, starting from the second day after surgery (Table
III, Fig. 2a and 2b). The mean difference in nitrogen balance between the 2
treatment groups was 13 g of nitrogen in 5 days in favor of the structured
triglyceride emulsion, which means that 80 g of protein or - in case this protein was
completely derived from muscle - approximately 500 g of muscle mass was saved
over 5 days by using the structured triglyceride emulsion. The daily amount of
nitrogen administered to the patients was a little higher in the structured
triglyceride-emulsion group, but based on the weight of the patients and calculated
as 0.2 g of nitrogen/kg body weight per 24 h. Indeed the weight of the patients in
the structured triglyceride-emulsion group was not significantly higher than the
weight of the patients in the physical mixture-emulsion group. Patients with a
higher weight have in a steady state condition a higher nitrogen loss. We found that
the patients in the structured triglyceride-emulsion group with a higher weight had
a lower nitrogen loss, indicating that the nitrogen balance is improved by the
treatment with the structured triglyceride emulsion. The difference in blood loss
during surgery between the 2 groups could not explain the difference in nitrogen
balance because it was too small to affect the calculations. Moreover, the nitrogen
balance study started the day after surgery. Our results agree with findings in
laboratory animals: structured triglyceride emulsions improved protein retention
compared with emulsions of a physical mixture of medium-chain and long-chain
triglycerides (12-14). 
We also studied serum triglycerides and plasma medium-chain free fatty acids and
observed that the levels of serum triglycerides and plasma medium-chain free fatty
acids increased less during infusion of the structured triglyceride emulsion than
with the physical mixture emulsion. Both groups received an equal dose of lipid
emulsion in weight; thus, the physical mixture-emulsion group received 1.08 times
more triglycerides and 1.25 times more medium-chain fatty acids, both on a molar
base. However, this does not explain that serum triglycerides and medium-chain
free fatty acids increased 2 times more with the physical mixture-emulsion group.
The smaller increase of serum triglycerides and plasma medium-chain free fatty
acids during infusion of the structured triglyceride emulsion may be due to a faster
use of the structured triglycerides than of the triglycerides in the physical mixture-
emulsion. On day 5 the differences between the 2 lipid emulsions were not
significant, possibly because patients were less stressed on day 5  than on day 1.
Another explanation to the decrease in changes of serum triglyceride levels on day
5 may be due to the increase in basal levels. This increase in basal levels is most
likely due to a too short infusion free period, so the triglycerides were not fully
removed from the circulation at the sampling time. The lack of difference in changes
in plasma medium-chain free fatty acid concentrations may be due to the small
group size: there is a tendency to difference and the changes are similar to the one
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observed on day 1. These findings are in agreement with findings in healthy volun-
teers: structured triglyceride emulsions caused lower plasma levels of medium-
chain free fatty acids and were cleared faster from the blood than emulsions of a
physical mixture of medium- and long-chain triglycerides (10,11).
One could speculate on the mechanism by which the structured lipids improve
nitrogen balance. The present study demonstrates a faster clearance of structured
lipid compared with the emulsion of medium- and long-chain triglycerides. A study
in patients comparing the administration of structured triglycerides and long-chain
triglycerides demonstrated a faster clearance and an increase in oxidation rate (16).
This suggests that structured triglycerides are hydrolyzed and oxidized faster.
This is also suggested by the study of Hultin et al. (26). The hypothesis in this study
was that the positional specificity of lipoprotein lipase should lead to differences in
metabolism of a long-chain fatty acid in the 2-position of triglycerides, compared
with one in the 1,3-position. In-vitro experiments have shown that in physical
mixtures of long-chain and medium-chain triglycerides, the medium-chain
triglycerides are hydrolyzed more rapidly, and the remnant particles become
enriched in long-chain triglycerides (27). Also, the lipoprotein lipase shows
specificity to the 1,3-position, resulting in the products fatty acids and 2-
monoglycerides (28). Monoglycerides recirculate in the plasma to a lesser degree
than fatty acids (29). According to these observations, a structured triglyceride with
a medium chain fatty acid-long chain fatty acid-medium chain fatty acid (MLM)
structure should be cleared faster, compared with long-chain triglycerides or a
physical mixture of medium-chain and long-chain triglycerides. In this study a
MLM structured triglyceride was compared with long-chain triglycerides and a
physical mixture. The hypothesis was confirmed. The clearance and oxidation of
MLM was faster, but oxidation was faster only in fasted unanaesthetized rats. The
differences were small. In this study no other molecular forms of structured
triglycerides were studied. The study of Hultin explains only in part the
observations in our study. 
The second question is the relation between the faster clearance and oxidation of
structured triglycerides and the influence on the protein metabolism. This faster
oxidation of structured triglycerides indicates a preference for structured triglycerides
as an energy source. Structured triglycerides influence the nitrogen metabolism and
may induce a protein saving effect by an increase in protein production or decrease in
protein breakdown. Animal studies demonstrated an increase in hepatic protein
synthesis (13,14) and decreased leucine oxidation (12,14). The process that regulates
this change in protein metabolism, is not yet fully studied.
In conclusion, in moderately catabolic patients the parenteral structured
triglyceride emulsion improves the nitrogen balance and is cleared faster from the
blood, compared with a physical mixture of medium- and long-chain triglycerides.
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Abstract
Background Studies gave indications that parenteral lipid emulsions suppress host
defense mechanisms. A previous study showed that intravenous administration of
a long-chain triglyceride emulsion impaired the phagocytosing capacity of the
mononuclear phagocyte system, determined by measuring the clearance of 
99m Technetium-Sulfur- (99m Tc-S-) colloid from the blood, in contrast to an emulsion
of a physical mixture of medium- and long-chain triglycerides.
Methods In a randomized, double-blind, parallel study, we investigated the
influence of intravenously administered triglyceride emulsions containing medium-
chain fatty acids on the 99m Tc-S-colloid clearance from the blood in 13 patients after
major vascular surgery. Seven patients received an emulsion of a physical mixture of
medium- and long-chain triglycerides and 6 patients a structured triglyceride
emulsion, in a dose of 0.11 g/kg/h over 6 hours daily. Structured triglycerides
consist of triglycerides where the medium- and long-chain fatty acids are attached
to the same glycerol molecule. 
Results The 99m Tc-S-colloid clearance from the blood was the same in the two study
groups, before the administration of lipid emulsion, as well as after 5 days of
treatment, and did not change during treatment.
Conclusions Parenteral lipid emulsions with medium-chain fatty acids do not
impair the mononuclear phagocyte system. In this respect there is no difference
between the effects of an emulsion of a physical mixture of medium- and long-chain
triglycerides and a structured triglyceride emulsion. 
Introduction
Conventional lipid emulsions in total parenteral nutrition contain long-chain
triglycerides, emulsified by phospholipids. Besides long-chain triglyceride
emulsions, medium-chain triglyceride emulsions are used, because they improve
nitrogen balance (1,2) and because they are utilized more rapidly (3). Medium-chain
triglycerides are given together with long-chain triglycerides as a physical mixture
emulsion, in order to supply essential long-chain fatty acids and to reduce side
effects as induced by high levels of medium-chain free fatty acids, such as metabolic
acidosis (4). Recently, structured triglyceride emulsions were synthesized. They
consist of triglycerides where the medium- and long-chain fatty acids are attached
to the same glycerol molecule (Fig. 1). Such structured triglycerides further reduce
plasma levels of medium-chain free fatty acids and do improve nitrogen balance (5).
All these parenteral lipid emulsions are sterile and pyrogen-free. 
Suppression of  the function of the mononuclear phagocyte system by parenteral
long-chain triglyceride emulsions has been reported (6). The mononuclear
phagocyte system comprises all highly phagocytic mononuclear cells as well as their
precursors (7). The function of the mononuclear phagocyte system can be evaluated 
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in-vivo by measuring the clearance of 99m Tc-S-colloid from the blood (8,9). Seidner
et al. reported that 3 days of parenteral administration of a long-chain triglyceride
emulsion to patients reduced the 99m Tc-S-colloid clearance (8). In contrast, in a
patient study by Jensen et al., 3 days parenteral administration of an emulsion of a
physical mixture of medium- and long-chain triglycerides did not change the 99m Tc-
S-colloid clearance from the blood (9). No studies have been performed as yet
investigating the effect of a structured triglyceride emulsion on 99m Tc-S-colloid
clearance.
Our objective was to study in post-operative patients the influence of parenteral
infusion of an emulsion of a physical mixture of medium- and long-chain
triglycerides or a structured triglyceride emulsion on the mononuclear phagocyte
system. For that purpose we used the in-vivo 99m Tc-S-colloid clearance test and
compared the change in pharmokinetics of 99m Tc-S-colloid after lipid 
administration, between the two patient groups, as described by Seidner et al. (8).
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Figure 1. The molecular structure of long-chain triglycerides, structured
triglycerides, and medium-chain triglycerides.
Methods
Patients
In this randomized, double-blind, parallel study we included patients electively
operated for placement of an aortic tube or bifurcation prosthesis because of an
abdominal aortic aneurysm or atherosclerotic obstruction. Such patients make a
homogeneous group, are moderately catabolic, and may require post-operative
parenteral nutrition. 
Exclusion criteria for this study were age above 80 years, diseases requiring fluid
restriction, unstable cardiac disease or myocardial infarction, renal or liver disease,
sepsis, severe malnourishment or overweight, diabetes mellitus,
hypertriglyceridemia or treatment with lipid lowering-drugs, steroid hormones,
chemotherapy or radiotherapy. 
All patients were informed orally and in writing, after which they gave their written
consent and were randomized. Thirteen patients, 11 men and 2 women, were 
included; 6 patients were in the structured triglyceride group and 7 patients in the
physical mixture group. Their mean age was 66.8 years (range 51 - 76 years) and
their mean weight 75 kg (range 52 - 91 kg). The study belongs to category I (up to
0.5 mSv) of the WHO classification and was approved by the Human Ethics
Committee of the University of Nijmegen, The Netherlands.
Treatment
Total parenteral nutrition was administered for the first 5 days after surgery. We
calculated energy requirement in kcal/24 h using Harris and Benedict's equation
[males: 66.47 + 13.75 x weight (kg) + 5.0 x height (cm) - 6.76 age (years); females:
655.10 + 9.56 x weight (kg) + 1.85 x height (cm) - 4.68 x age (years)] and added 300
kcal/24 h for activity. We gave 0.2 g of nitrogen/kg body weight per 24 hours or 21
energy % as amino acids (Vamin 18, Fresenius-Kabi, Sweden). Two thirds of the
remaining non-protein energy or 53 energy % was given as carbohydrates (glucose
40%) and one third or 26 energy % as lipid emulsion. The lipid emulsion was a
structured triglyceride emulsion (Structolipid, Fresenius-Kabi, Sweden) or an
emulsion of a physical mixture of medium- and long-chain triglycerides
(Lipofundin MCT/LCT 20%, B. Braun Melsungen AG, Germany) (Table I). The
dose of lipid emulsion was 0.11 g/kg/h over 6 hours daily. During the first 5 days
after surgery, amino acids and carbohydrates were given daily over 24 hours. The
lipid emulsions were administered daily from 10 AM to 4 PM. Amino acids,
carbohydrates and lipid emulsion were given at constant rates using three separate
infusion pumps (Terufusion STC-503, Terumo, The Netherlands). All parenteral
fluids were sterile and pyrogen-free. Oral intake of nutrients was not allowed
during the study period.
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Preparing of Antimone-Sulfur-pre-colloid
Hundred mg of K(SbO)C4H4O6-0.5H20 (Merck, Germany) was dissolved in 5 mL
of water. This was slowly added to 50 mL of boiling water, saturated with H2S
(F.I.L. Hoekloos, The Netherlands). The colloid was stabilized with 240 mg poly-
vinylpyrrolidon (K25) (Fluka, Switzerland) and the solution was heat sterilized.
Labeling and preparing of 99m Tc-S-colloid
Two mL of the pre-colloid, 1 mL 0.1 M HCL (Merck, Germany) and 740 MBq 
99m Tc-pertechnetate (Mallinckrodt, The Netherlands) was heated for 15 minutes at
120 °C. The radiochemical purity of the 99m Tc-S-colloid was determined by instant
thin layer chromatography (ITLC) on Gelman-ITLC-SG strips (Gelman
Laboratories, MI) with sterile saline 0.9% as mobile phase: more than 99% of the
99m Tc-S-colloid was found at the origin of the chromatogram. One mL of 0.15 M
Na-acetate buffer (pH 7.0) (Merck, Germany) was added to neutralize the colloid
and the colloid was sterilized by leading the solution over a 0.22 µm millipore filter.
45
Table I. Composition and characteristics of the structured triglyceride emulsion and
of the emulsion of the physical mixture of medium- and long-chain triglycerides
Composition and characteristics Structured Physical
triglyceride mixture
emulsion emulsion
Structured triglycerides (g/L) 200
Soy bean oil (g/L) 100
Medium-chain triglycerides (g/L) 100
Mean molecular weight of
triglycerides 683 634
Fractionated egg phospholipids (g/L) 12 12
Glycerol (USP) (g/L) 22.5 25.0
Water for injection ad (mL) 1000 1000
pH 8 6.5-8.5
Osmolality (mOsm/kg water) 350 380
Energy content (kcal/L) 1960 1936
Fatty acid composition, % by weight
Caprylic acid (C8:0) 27 26
Capric acid (C10:0) 10 20
Palmitic acid (C16:0) 7 7
Stearic acid (C18:0) 3 2.5
Oleic acid (C18:1) 13 13
Linoleic acid (C18:2ω6) 33 27
Alpha-linolenic acid (C18:3ω3) 5 3.5
Other 2 1
Finally, the solution was diluted with sterile saline 0.9% to a concentration of 20
MBq in 5 mL.
Assessment
A bolus of 20 MBq of 99m Tc-S-colloid was administered intravenously in 5 mL,
using a peripheral venous catheter in one arm. To guarantee equal intravascular
distribution, the bolus was flushed immediately with 10 mL of sterile saline 0.9%.
By a winged infusion set, put into a vein of the other arm, serial blood samples of 2
mL each were drawn into heparinized tubes. Blood samples were taken at 1.5, 3,
4.5, 6, 9, 12, 15, 30 and 60 minutes after injection and centrifuged at 2600 rpm.
Plasma samples of 0.5 mL were counted in a Wizzard-3-1480 Wallac Gamma
Counter and compared with a standard solution, prepared from the injection dose.
The plasma activity was expressed in percents of injected activity per mL plasma, as
a function of time.
A two-compartment model as described by Seidner et al. (8) was used to assess 
99m Tc-S-colloid clearance from the blood by the mononuclear phagocyte system.
The plasma data were analyzed by nonlinear least-squares fit, using a 
bi-exponential model and plasma clearance was calculated in mL per minute, using
the following formula: 
KA * KB * D                              
Cl (mL/minute)  =    __________         
A0KA + B0KB
Cl = clearance of 99m Tc-S-colloid from the plasma (mL/minute)
KA = regression coefficient of the fast phase (minute-1)
KB = regression coefficient of the slow phase (minute-1)
D = injected activity (counts)
A0 = fraction of injected activity in plasma of the fast phase (counts/mL)
B0 = fraction of injected activity in plasma of the slow phase (counts/mL) 
Statistics
The two-tail probation test was used to calculate differences in 99m Tc-S-colloid
clearance from the blood between the two treatment groups, before the start of total
parenteral nutrition on the first post-operative day, and after 5 days of total
parenteral nutrition (10). The same test was used to calculate differences in change
of 99m Tc-S-colloid clearance from the blood between the treatment groups after 5
days of total parenteral nutrition (difference between 99m Tc-S-colloid clearance
before treatment and after 5 days of treatment). All results were expressed as mean
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± SD. The number of patients in the study was calculated using the differences seen
during administration and using the data of Seidner et al. (8).
Results
Figure 2 shows graphically the results of one patient. We expressed the activity of
99m Tc-S-colloid in percents of injected activity per mL plasma, as a function of time.
This plasma activity was measured in blood samples before the start of total
parenteral nutrition, on the first post-operative day, and after 5 days of total
parenteral nutrition. No significant differences between samples before and after
administration of total parenteral nutrition were observed.
For both treatment groups, before administration of total parenteral nutrition, on
the first post-operative day, the clearance of 99m Tc-S-colloid from the blood was the
same (192 ± 66 mL/min in the structured triglyceride group, and 202 ± 34 mL/min
in the physical mixture group, p > .05) (Table II). Two patients in the physical
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Figure 2. The activity of 99mTc-S-colloid in percents of injected activity per mL
plasma in blood samples before treatment and after 5 days of intravenous
administration of a structured triglyceride emulsion (STG). Plasma activity is
expressed as a function of time. No significant differences between samples before
and after treatment were observed (results of one patient). The same results were
obtained with intravenous administration of an emulsion of a physical mixture of
medium- and long-chain triglycerides (not shown).
mixture group did not complete the study, for reasons not related to the lipid
emulsion or the study: aspiration of stomach contents and repeated ventricular
fibrillation. After 5 days of total parenteral nutrition, the 99m Tc-S-colloid clearance
from the blood was not changed significantly (+14 ± 74 mL/min in the structured
triglyceride group, n=6, and -20 ± 57 mL/min in the physical mixture group, n=7,
p > .05) and still the same for both groups (206 ± 62 mL/min in the structured
triglyceride group, n=6, 183 ± 94 mL/min in the physical mixture group, n=7, 
p > .05) (Table II). 
Discussion
Our results in patients show that the clearance of 99m Tc-S-colloid from the blood is
unchanged after 5 days of total parenteral nutrition with an emulsion of a physical
mixture of medium- and long-chain triglycerides or a structured triglyceride
emulsion, in a dose of 0.11 g/kg/h over 6 hours daily. This indicates that emulsions
of both a physical mixture and structured triglycerides, containing triglycerides
with medium-chain fatty acids, do not suppress the mononuclear phagocyte system
function. 
Earlier, Seidner et al. (8) reported in a patient study, that 3 days of parenteral
administration of a long-chain triglyceride emulsion, at 0.13 g/kg/h over 10 hours
daily, reduced the clearance of 99m Tc-S-colloid from the blood. One day of
parenteral treatment with a long-chain triglyceride emulsion did not affect the 
99m Tc-S-colloid clearance (8) or the 125I-microaggregated human serum albumin
clearance (11). In another study by Jensen et al. (9) the same daily dose of long-
chain triglyceride emulsion, 1.3 g/kg/day, was given continuously over 3 days, and
did not impair the mononuclear phagocyte system. These findings suggest that
lower total dose, shorter infusion period and lower dose rate of infusion of long-
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Table II. 99mTc-S-colloid (TSC) clearance from the blood (mL/minute) before
treatment and after 5 days of parenteral administration of a structured triglyceride
emulsion or an emulsion of a physical mixture
Structured Physical
triglycerides mixture
n = 6   n = 7
TSC clearance before treatment 192 ± 66 202 ± 34 
TSC clearance after treatment 206 ± 62 183 ± 94
Change in TSC clearance +14 ± 74 -20 ± 57
Values are means ± SD.
chain triglyceride lipid emulsions cause less impairment of the mononuclear
phagocyte system. 
In accordance to our results, Jensen et al. (9) reported in the same study  that 3 days
parenteral administration of an emulsion of a physical mixture of medium- and
long-chain triglycerides, at 0.13 g/kg/h over 10 hours daily, did not change the
99mTc-S-colloid clearance from the blood. 
In-vitro and animal studies on phagocytosis are scarce, have conflicting results and
concern mainly long-chain triglyceride emulsions. In-vitro incubation with a long-
chain triglyceride emulsion impaired phagocytosis by murine peritoneal
macrophages (12), but improved chemotaxis and phagocytosis by human monocytes
(13). In two animal experiments, intraperitoneal administration of a long-chain
triglyceride emulsion impaired bacterial clearance from the peritoneal cavity (12)
and the blood (14). In another animal study intravenous administration of a long-
chain triglyceride emulsion did not change bacterial clearance from the blood (15).
Interestingly, the last animal study showed a different pattern of bacterial organ
sequestration by intravenous administration of a long-chain triglyceride emulsion,
compared with a medium-chain triglyceride or structured triglyceride emulsion
(15). In contrast to a medium-chain triglyceride or structured triglyceride emulsion,
the long-chain triglyceride emulsion reduced bacterial uptake in the liver and
increased bacterial uptake in the lungs, suggesting overload of the mononuclear
phagocyte system in the liver with increased bacterial sequestration in the lungs.
Hamawy et al. (16) reported increased bacterial clearance from the blood in animals
treated with intravenous administration of a physical mixture emulsion, compared
with a long-chain triglyceride emulsion or controls without lipid emulsion. The
same pattern of organ sequestration was observed: liver uptake of bacteria was
reduced with the long-chain triglyceride emulsion and enhanced with the physical
mixture emulsion, compared to controls without lipid emulsion; lung uptake of
bacteria was enhanced with the long-chain triglyceride emulsion and reduced with
the medium-chain triglyceride emulsion, compared with controls without lipid
emulsion. Pscheidl et al. (17) compared the effects of intravenous administration of
a structured triglyceride emulsion with an emulsion of a physical mixture on
bacterial organ sequestration in animals. Bacterial sequestration in the animals
treated with the structured triglyceride emulsion was higher in the liver and spleen
and lower in the lungs compared with the animals treated with the emulsion of the
physical mixture, implicating a further improvement of mononuclear phagocyte
function by structured triglyceride emulsions.
The mechanism by which parenteral long-chain triglyceride emulsions impair
mononuclear phagocyte function is still not clear. One of the explanations is the
process of engulfment of lipid particles by macrophages, after which further
phagocytosis of bacteria is impaired (11). Other explanations involve alterations in
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membrane composition by the infused lipids, which can change the qualities of the
membrane such as deformability and fluidity, and expression of receptors (11,13).
In conclusion, in contrast to a long-chain triglyceride emulsion, an emulsion of a
physical mixture of medium- and long-chain triglycerides and a structured
triglyceride emulsion, both containing triglycerides with medium-chain fatty acids,
do not impair the mononuclear phagocyte system in patients.
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Abstract
The relation between the immune and neuroendocrine response during surgery was
studied. In 18 patients undergoing major vascular surgery, circulating interleukin
(IL)-1ß, and ex-vivo production of IL-1ß and tumor necrosis factor (TNF)-α were
lower on day 1 after surgery compared to pre-operation values (-14 ± 5%, p<0.05;
-62 ± 9%, p<0.05; and -31 ± 54%, p<0.005, respectively). Circulating IL-1 receptor
antagonist (IL-1ra) was higher on the 5th day post-operatively compared to pre-
operation values (mean +640% ± 400, p<0.05).
In a more detailed study in 6 patients, the ex-vivo production of IL-1ß and TNF-α
started to decrease at induction of general anesthesia and dropped to under 10% of
initial values at the end of surgery. Circulating IL-1ra and ex-vivo production of IL-
1ra started to increase at the end of surgery and remained elevated up to 6 days
post-operatively. Plasma antidiuretic hormone (ADH) and adrenocorticotropic
hormone (ACTH) increased during surgery, but cortisol remained unchanged. 
We demonstrate a depression of circulating pro-inflammatory IL-1ß and an
increase of circulating anti-inflammatory IL-1ra during surgical stress. The ex-vivo
production of IL-1ß and TNF-α was suppressed, indicating a downregulation of
the production of these cytokines. This paralleled the hormonal reaction with high
ADH and ACTH, but not of cortisol, suggesting that glucocorticoid is not the key-
factor in downregulation of production and release of pro-inflammatory cytokines.
Introduction
Surgery elicits a physiological response (1,2) characterized by suppression of the
immune system (3) and stimulation of the neuroendocrine system (4). The immune
response during surgery involves almost every component of the immune system,
such as function of phagocytes and lymphocytes (5-8). The neuroendocrine response
during surgery leads to an increased secretion of adrenocorticotropic hormone
(ACTH), growth hormone, prolactin and antidiuretic hormone (ADH) from the
pituitary. Secondary changes include stimulation of cortisol and aldosterone
production and inhibition of insulin and somatomedin secretion (4). At the same time
the equilibrium between the sympathetic and parasympathetic autonomic nervous
systems is shifted towards the sympathetic system leading to the release of
noradrenaline from presynaptic sympathetic fibers and adrenaline from the adrenal
medulla (4).The neuroendocrine and the immune system are intimately linked and
involved in bidirectional communication (9). Both systems share the same set of signal
molecules (hormones and cytokines) and their receptors. Glucocorticoids inhibit LPS-
induced increase in interleukin (IL)-1ß mRNA transcription and selectively inhibit the
stability of IL-1ß mRNA (10). ACTH inhibits directly interferon-γ production by T-
lymphocytes in vitro (11). On the other hand, chronic administration of IL-1 induces
a dose-dependent and long-term increase of plasma levels of ACTH and
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corticosterone in rats (12), possibly by an action on the hypothalamus and pituitary
gland. Thus, classical hormones can inhibit immunological cell function and products
of immune cells can stimulate the hypothalamic-pituitary-adrenal axis. 
We addressed the question to what extent cytokine production and release, and
plasma concentrations of ACTH, cortisol and ADH were affected by surgery, and
searched for a time relation between the cytokine and neuroendocrine
response during surgery.
Results
In 18 patients undergoing major vascular
surgery plasma levels of circulating
interleukin (IL)-1ß, tumor necrosis factor
(TNF)-α and IL-1 receptor antagonist (IL-
1ra), and ex-vivo production of IL-1ß,
TNF-α and IL-1ra were measured. To
compare data results are expressed as
percentage of pre-operative values. Figure 1
shows that the plasma level of circulating
IL-1ß was significantly lower (-14 ± 5%,
p<0.05) on the first post-operative day
compared to pre-operative values (0.10 ±
0.003 ng/mL). On the 5th day after
operation the level had returned to initial
values. Plasma levels of circulating TNF-α
and IL-1ra had not changed significantly
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Figure 1. Plasma levels of circulating (open
bars) and ex-vivo production (closed bars) of
IL-1ß (A), TNF-α (B) and IL-1ra (C) in 18
patients, on the first day and the fifth day
post-operatively. Data are expressed as
percentage of pre-operative values. On the
left side of the figure are the results on day 1
and on the right side the results on day 5.
Open bars are plasma levels of circulating IL-
1ß, TNF-α and IL-1ra respectively; closed
bars are ex-vivo production of IL-1ß, TNF-α
and IL-1ra respectively. * indicates statistical
significance at p < 0.05 and ✝ at p < 0.005.
one day after operation (pre-operative values 0.1 ± 0.01 ng/mL and 0.3 ± 0.04
ng/mL, respectively). On the 5th post-operative day however, the plasma level of
circulating IL-1ra was found to be significantly increased (mean +640% ± 400,
p<0.05) compared to the pre-operative level. 
The ex-vivo production of IL-1ß and TNF-α was significantly lower after surgery
(from pre-operatively to the first day post-operatively mean -62% ± 9, p<0.05 and
-31% ± 54, p<0.005, respectively), whereas the production was increased, although
not significantly, on day 5 after operation (pre-operative values 6.0 ± 0.68 ng/mL,
4.1 ± 0.69 ng/mL, respectively). Compared to pre-operative values (10.9 ± 0.50
ng/mL), the ex-vivo production of IL-1ra remained unchanged on day 1 and day 5
after operation (Fig. 1).
To obtain more insight in the patterns of cytokine release and production, in 6
patients 14 blood samples were taken peri-operatively with short intervals (Table I). 
As shown in Figure 2 plasma levels of circulating IL-1ß and TNF-α showed no
remarkable changes. The plasma level of circulating IL-1ra, however, started to
increase from 0.2 ng/mL at 60 minutes after skin incision to 0.6 ng/mL at the end
of surgery, and even further increased to 0.8 ng/mL at the first day post-operatively.
Thereafter circulating IL-1ra plasma levels sharply decreased, but remained
elevated on a level of approximately 0.5 ng/mL for at least 6 days. 
The basal ex-vivo cytokine production values ranged between 2.9 - 19.0 ng/mL (IL-
1ß), 0.6 - 6.9 ng/mL (TNF-α) and 10.5 - 13.5 ng/mL (IL-1ra) respectively. Again,
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Table I. Time schedule for collecting blood samples in the subgroup of 6 patients.
During operation:
1. Pre-induction, 10 min after insertion of a radial artery catheter 
2. 5 min after intubation
3. 5 min after skin incision
4. 20 min after skin incision 
5. 40 min after skin incision
6. 60 min after skin incision 
7. 120 min after skin incision
8. end of surgery
Post-operative:
9. post-operatively day 1 at 8 AM
10. post-operatively day 2 at 8 AM
11. post-operatively day 3 at 8 AM
12. post-operatively day 4 at 8 AM
13. post-operatively day 5 at 8 AM
14. post-operatively day 6 at 8 AM
for reasons of comparison, ex-vivo production data are expressed as percentage of
pre-operative values (Fig. 3). The ex-vivo production of IL-1ß and TNF-α started
to decrease immediately after intubation and skin incision and decreased to 9 % and
6% of initial values at the end of surgery. In the post-operative period the
production returned to baseline values. The ex-vivo production of IL-1ra on the
other hand showed only a slight decrease during surgery (-25 % of initial value at
40 min after skin incision), and already during surgery the production started to
rise. After surgery IL-1ra production further increased and remained elevated up to
the 6th day post-operatively (Fig. 3). 
Five of these patients were randomly selected to measure also ACTH, cortisol and
ADH (Fig. 4). Plasma ACTH concentrations showed a peak of 10 pmol/L at 20
min after skin incision and a second much larger peak of 30 pmol/L at the end of
surgery. Post-operatively ACTH concentrations rapidly decreased, and again were
slightly elevated (10 pmol/L) on the sixth day after operation. Plasma cortisol
concentrations did not significantly change during the surgical procedure. 
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Figure 2. Time course of plasma levels of circulating cytokines in six patients.
IL-1ß, open circles; TNF-α, closed squares; and IL-1ra, closed circles (ng/mL):
sampling codes 1 to 8 signify sampling during operation; sampling codes 9 to 14 signify
post-operative sampling. Detailed explanation for the time schedule for collecting
blood samples is given in Table 1. The horizontal bar indicates the period of surgery. 
On the first day after surgery, however, cortisol concentrations increased to 0.6
µmol/l and remained elevated up to the end of the study period. Plasma levels of
ADH showed a prominent peak of approximately 30 pmol/L at 5 min after skin
incision and a second peak also of approximately 30 pmol/L, at the end of surgery.
Post-operatively ADH plasma values returned to baseline levels.
To investigate whether the observed effect was a result of blood loss, hemodilution
or decrease of amount of mononuclear cells during surgery, hemoglobin
concentration and mononuclear cell count were determined in the blood specimens.
Hemoglobin concentration was measured in five patients and decreased only
slightly at the end of surgery. Blood leukocyte count was performed in two patients
and showed a small decrease during surgery and a small rise after surgery.
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Figure 3. Time course of ex-vivo production of cytokines in six patients.
IL-1ß, open circles; TNF-α, closed squares; and IL-1ra, closed circles. 
Data are expressed as percentage change versus pre-induction values (code of
sampling 1). Sampling codes 1 to 8 signify sampling during operation; sampling codes
9 to 14 signify post-operative sampling. Detailed explanation for the time schedule
for collecting blood samples is given in Table 1. The horizontal bar indicates the
period of surgery.  
Discussion 
We studied plasma levels of circulating cytokines and ex-vivo cytokine production
during the surgical stress response and observed in a group of 18 patients a small,
but significant, depression of circulating pro-inflammatory IL-1ß level on day 1
post-operatively, and an increase in circulating anti-inflammatory IL-1ra level, on
day 5 post-operatively. On day 1 post-operatively the ex-vivo production of IL-1ß
and TNF-α was depressed. In the group of 6 patients for determination of a more
detailed cytokine pattern, we could not detect the above-mentioned small
depression of plasma levels of circulating IL-1ß, which we found in the larger group
of 18 patients. The number of patients was probably too small and the difference
only of borderline significance. In both studies blood mononuclear cell count and
hemoconcentration changed only slightly, and blood loss was small, and therefore
could not explain for the major changes in cytokine production and release.
Depression of circulating and ex-vivo production of pro-inflammatory cytokines in
combination with elevation of circulating anti-inflammatory cytokines like IL-1ra
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Figure 4. Time course of hormonal measurements in five patients.
ACTH (pmol/L), open circles; ADH (pmol/L), closed squares; and cortisol (µmol/l),
closed circles. For explanation of code of sampling see Table 1.
has been described during the acute phase of typhoid fever (13), meningococcal
infection (14) and Pneumocystis carinii infection (15). Studies with isolated
peripheral blood mononuclear cells or tissue macrophages showed low production
capacity of cytokines in post-operative infection (16), sepsis (17-19) and attacks of
familial Mediterranean fever (20,21).
The ex-vivo production of IL-1ß and TNF-α started to decrease already from the
moment of insertion of the radial artery catheter, whereas plasma levels of
circulating IL-1ra, ACTH and ADH increased during surgery. The plasma level of
cortisol did not change during surgery, but was increased in the post-operative
phase. The depression of ex-vivo IL-1ß and TNF-α production preceded the rise in
the stress hormone cortisol and its regulator ACTH. In animal experiments, it has
been shown that the neuroendocrine system and the immune system are intimately
linked and involved in bidirectional communication (9). Both systems share the
same set of signal molecules (hormones and cytokines) and their receptors. Thus,
although a direct relation between production of cortisol and cytokines has been
reported in literature, the late cortisol response in the present study strongly
suggests that this immunosuppressive glucocorticoid is not a primary key player in
the downregulation of synthesis and release of the pro-inflammatory cytokines
during the surgical stress response.
Our findings support the hypothesis that the depression of IL-1ß and TNF-α
production and the increase of circulating IL-1ra level, is caused by a switch of
cytokine-producing cells from a mainly pro-inflammatory to an anti-inflammatory
repertoire, and not by an exhaustion of productive capacity of the immune cells or
an enhanced lysis of cytokine-producing cells (13,14). The present study shows that
not only in infectious disease or fever these cytokine changes are present, but also
during surgery. Therefore, this switch in cytokine pattern could be part of a general
physiological stress response with a common mechanism of cytokine changes in
stress situations like surgery, febrile disease and sepsis. Interestingly, Keuter et al.
(13) found a lower cytokine production in patients with complicated typhoid fever
than in patients with uncomplicated disease, suggesting that the degree of injury or
stress is correlated with the degree of changes in cytokine pattern.
Pro-inflammatory cytokines are thought to be important for an adequate host
defence. Depression of these pro-inflammatory cytokines and an increase of anti-
inflammatory cytokines during surgery can cause suppression of the immune
response and an increase in the risk of infectious complications. More knowledge
on the mechanism of changes in cytokines and hormones and their mutual relation
in the surgical stress response, may be important in the prevention of 
post-operative infectious complications. 
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Materials and methods
The study was approved by the Human Ethics Committee of the University of
Nijmegen Academic Hospital. All patients were informed orally and in writing
after which they gave their written consent.
Patients
In 18 patients (14 men and 4 women; age 53 to 78 years) undergoing elective
implantation of an aortic bifurcation or tube prosthesis because of an abdominal
aortic aneurysm or atherosclerotic obstruction, blood was drawn pre-operatively,
on the first day post-operatively and on the fifth day post-operatively, for
measurement of cytokines. Patients with endocrine or immune diseases were 
excluded from the study. 
In six patients undergoing the same type of operation and not treated with
glucocorticoids, 14 blood samples were collected starting 10 min after insertion of
a radial artery catheter, prior to induction of general anesthesia, up to 6 days post-
operatively (Table I), for determination of a more precise cytokine pattern. In five
of these patients plasma levels of ACTH, cortisol and ADH were also measured.  
Blood collection and handling
Blood for measurement of ACTH, ADH and cortisol was collected in pre-chilled
EDTA-K3 tubes (Vacutainer Systems, Becton and Dickinson, Rutherford, NJ) and
centrifuged for 10 min at 1500 x g (4 °C). The plasma obtained was aliquoted in
polystyrene tubes containing 25 µL TrasylolR (aprotinin, 10 000 kallikreine
inactivating units (KIU)/mL; Bayer, Leverkusen, Germany). Blood for
measurement of circulating cytokines was drawn in 4 mL EDTA-K3 tubes
containing 250 µL TrasylolR. The tubes were centrifuged immediately at 2000 x g
for 10 min and the resulting plasma at 15 000 x g for 5 min to obtain platelet-poor
plasma. Aliquots were stored at -20 0C until assay. The ex-vivo production of
cytokines was measured in whole blood using two 4 mL EDTA-K3 tubes
containing 250 µL TrasylolR (22). Fifty microlitres LPS (final concentration 10
µg/mL; E. coli serotype 055:b5; Sigma, St. Louis, USA) was added under sterile
conditions to one tube; the other tube was incubated without LPS. After 24 h
incubation at 37 0C, both tubes were centrifuged and the plasma handled as 
described above. 
RIA for cytokines
IL-1ß, TNF-α and IL-1ra were measured in duplicate by radioimmunoassay (RIA)
as described previously by Drenth et al. (23). The sensitivity of the assays was 0.060
ng/mL (IL-1ra), 0.040 ng/mL (IL-1ß) and 0.020 ng/mL (TNF-α), respectively. 
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Hormone measurement
ACTH
Extraction from plasma. ACTH was extracted and concentrated from plasma by
addition of 25 mg VycorR-glass powder (Corning Glass Works, New York, NY) in
250 µL bidistilled water to 500 µL aliquots of plasma. ACTH was eluted from the
glass pellet with acetone/bidistilled water (50/50). The acetone fractions were
evaporated to dryness and the residues were reconstituted in 250 µL of a solution
containing 0.9% NaCl and 0.25% BSA (pH 3.5). Standard curves were prepared by
spiking ACTH-free human plasma with ACTH (MRC 74/555). The standard
samples were subjected to the same extraction procedure as the unknowns. The
recovery was approximately 70%. All samples were extracted in duplicate.
RIA. ACTH-immunoreactivity in the supernatants was measured by RIA using a
commercial ACTH antibody (IgG Corporation, Nashville, USA) and 
[125 I]ACTH1-39 as tracer. The ACTH RIA was performed as follows: 100 µL rabbit
ACTH antiserum (final dilution 1:30 000 in RIA-buffer (phosphate buffer
containing 13 mM EDTA, 0.02% sodium azide, 0.25% BSA (ORHD 20/21,
Behring), 0.1% Triton X-100 and 250 kallikreine inactivating units (KIU)
Trasylol/mL)) was added to 100 µL sample or standard. The mixture was
preincubated for 3 days at 4 0C with antiserum. Then, tracer (approximately 7000
dpm/100 µL) was added and incubation was continued for another day. Bound and
free ACTH were separated by a second antibody system (10% sheep anti-rabbit
IgG and 0.01% rabbit IgG). The antibody complex was precipitated by addition of
1 mL 7.5% PEG 6000 (Merck). The sensitivity of the assay system was 1 pmol/L,
and the within- and between-assay coefficients of variation of the procedure were
9.1% and 15.3% respectively (12).
Cortisol
Plasma cortisol levels were measured by RIA using an antiserum raised in rabbit
against a cortisol-21-hemisuccinate-bovine serum albumin conjugate. Standard and
samples (50 µL) were diluted 1:100 with ethanol/water (5/95, v/v) and
corticosteroid binding globulin was denatured by incubation at 70 0C for 1 h.
Subsequently, tracer ([1,2,6,7-3H]cortisol) and antibody were added, and bound and
free hormone were separated by dextran-coated charcoal after incubation for 18 h
at 4 0C. After centrifugation the supernatants were decanted and radioactivity
measured. The sensitivity of the assay was 0.02 µmol/L. The within- and between-
assay coefficients of variation were 4.5% and 6.6% at 0.21 µmol/L. 
ADH
Extraction from plasma. Extraction of ADH was performed over Sep Pak C18
columns (Waters) with 1 mL acidified plasma aliquots. The column was washed
62
with 10 mL 4% acetic acid, 2 mL chloroform, and 10 mL 4% acetic acid, 
respectively. ADH was eluted with 4 mL 100% methanol. The recovery was
approximately 80%. Eluates were dried overnight in a Speedvac and the residues
redissolved in RIA buffer.
RIA ADH-immunoreactivity in the eluates was measured by RIA using an ADH
antibody (P31080, kindly provided by dr. D. Swaab, NIH, Amsterdam). ADH
(MRC77/501) was used as standard and [125 I]ADH as tracer. The ADH RIA was
performed as follows: 50 µL rabbit ADH antiserum (final dilution 1:60 000) was
added to 50 µL sample or standard. The mixture was preincubated for 3 days at 4
0C with antiserum. Then, tracer (approximately 7000 dpm/50 µL) was added and
incubation was continued for another day. Separation of bound and free ADH was
identical to that of the ACTH RIA. The sensitivity of the assay system was 0.8
pmol/L, and the within- and between-assay coefficients of variation of the
procedure were less than 8% (24).
Blood loss and mononuclear cell counting 
To estimate blood loss and hemodilution the hemoglobin concentration was
measured in five patients. Mononuclear cell count (monocytes and lymphocytes) in
peripheral blood of two patients was measured. Hemoglobin concentration and
mononuclear cell count was determined using an automated hematological analyzer
Sysmex NE-8000 (Charles Goffin Medical Systems bv, Tiel, The Netherlands). 
Statistics
For the group of 18 patients, differences in cytokine values between pre-operative
values and values on the first day post-operatively, and differences in cytokine
values between the first day post-operatively and the fifth day post-operatively,
were tested by Wilcoxon signed rank test.
The results of the additional study in the group of six patients, each giving 14 blood
samples, are presented in Figure 2, 3 and 4. In all six patients plasma levels of
cytokines were measured; in five of these patients plasma levels of ACTH, cortisol
and ADH were also determined. Data are presented as mean ± SEM.
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Addendum
A secondary aim of this study was to compare the influence of two parenteral lipid
emulsions, structured triglycerides and a physical mixture of medium- and long-chain
triglycerides, on cytokine production and neuroendocrine response during surgery.
At random, total parenteral nutrition with structured triglycerides or the physical
mixture was administered for the first 5 days after surgery as described in Chapter 5.
No differences were observed between the results of the group of patients treated
with structured triglycerides or with the physical mixture. The results of both
groups were combined.
The lack of difference between the results of the two lipid emulsions is most likely
explained by the overwhelming influence of surgery on cytokine production and
neuroendocrine response.
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WITH MEDIUM-CHAIN TRIGLYCERIDES, HIGHER AND FASTER OXYGEN
RADICAL PRODUCTION BY STIMULATED POLYMORPHONUCLEAR
LEUKOCYTES OCCURS
Joanna W. Kruimel, MD1
Ton H. Naber, MD, PhD1
Jo H. Curfs, PhD2
Mira A. Wenker1
Jan B. Jansen, MD, PhD1
1From the Department of Gastroenterology and Hepatology, 
and the 2Department of Medical Microbiology,
University Medical Center Nijmegen, Nijmegen, 
The Netherlands
Journal of Parenteral and Enteral Nutrition 24:107-112, 2000
Abstract
Background Parenteral lipid emulsions are suspected of suppressing the immune
function. However, study results are contradictory and mainly concern the
conventional long-chain triglyceride emulsions.
Methods Polymorphonuclear leukocytes were preincubated with parenteral lipid
emulsions. The influence of the lipid emulsions on the production of oxygen
radicals by these stimulated leukocytes was studied by measuring chemilumi-
nescence. Three different parenteral lipid emulsions were tested: long-chain
triglycerides, a physical mixture of medium- and long-chain triglycerides, and
structured triglycerides. Structured triglycerides consist of triglycerides where the
medium- and long-chain fatty acids are attached to the same glycerol molecule.
Results Stimulated polymorphonuclear leukocytes preincubated with the physical
mixture of medium- and long-chain triglycerides showed higher levels of oxygen
radicals (p < .005) and faster production of oxygen radicals (p < .005) compared
with polymorphonuclear leukocytes preincubated with long-chain triglycerides or
structured  triglycerides. Additional studies indicated that differences in results of
various lipid emulsions were not caused by differences in emulsifier. The overall
production of oxygen radicals was significantly lower after preincubation with the
three lipid emulsions compared with controls without lipid emulsion.
Conclusions A physical mixture of medium- and long-chain triglycerides induced
faster production of oxygen radicals, resulting in higher levels of oxygen radicals,
compared with long-chain triglycerides or structured triglycerides. This can be
detrimental in cases where oxygen radicals play a pathogenic role or  beneficial,
when rapid phagocytosis and killing of bacteria is needed. The observed lower
production of oxygen radicals by polymorphonuclear leukocytes in the presence of
parenteral lipid emulsions may result in immunosuppression by these lipids.
Introduction
Total parenteral nutrition (TPN) is nutrition administered directly into the
bloodstream of patients who are unable to meet their nutritional needs by using the
normal enteral route. The triglycerides in TPN are emulsified by phospholipids.
These emulsions are sterile and pyrogen-free. In a large study, more infectious
complications were observed in borderline and mildly malnourished patients, who
were peri-operatively treated with TPN, compared with controls not receiving
peri-operatively TPN (1). The infectious complications were mainly pneumonia
and wound infection. The authors suggested that the long-chain triglyceride
emulsion in the parenteral nutrition was a possible cause of this increased rate of
infections.
Conventional parenteral lipid emulsions are long-chain triglyceride emulsions.
These emulsions are made of soybean oil and consist of long-chain fatty acids. In
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addition to long-chain triglycerides, medium-chain triglycerides are used in
parenteral lipid emulsions, because in some studies they improve nitrogen balance
(2,3) and are utilized more rapidly (4). Medium-chain triglycerides consist only of
medium-chain fatty acids. Medium-chain triglycerides are always given together
with long-chain triglycerides as a physical mixture, in order to provide the essential
long-chain fatty acids and to reduce side effects such as metabolic acidosis (5) and
neurological toxicity (6) caused by high levels of medium-chain free fatty acids (Fig.
1). Recently, so-called structured triglycerides were synthesized to reduce the risk
of toxicity by medium-chain free fatty acids further. Structured triglycerides consist
of triglycerides where the medium- and long-chain fatty acids are attached to the
same glycerol molecule (Fig. 1). In our clinical trial on 25 moderately catabolic
patients after major vascular surgery, structured triglycerides caused lower plasma
concentrations of medium-chain free fatty acids (7) and improved nitrogen balance,
compared with the physical mixture of medium- and long-chain triglycerides (8).
The influence of various lipid emulsions on leukocyte function is still unclear. The
results of in-vitro studies, and in-vivo studies, both in volunteers and in patients, are
contradictory and concern mainly the conventional long-chain triglyceride
emulsions (9-26). Studies on the effects of the physical mixture on leukocyte
function are rare and inconclusive: in-vitro, the physical mixture impaired leukocyte
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Figure 1. A physical mixture of medium- and long-chain triglycerides consists of
triglycerides that contain either three long-chain fatty acids or three medium-chain fatty
acids. A structured triglyceride emulsion consists of triglycerides where the medium- and
long-chain fatty acids are randomly attached to the same glycerol molecule.
function (19,20) but infusion in volunteers and patients did not have any negative
effect on leukocyte function (27,28). Data on the effects of structured triglycerides
on leukocyte function are scarce, consisting of only two animal studies on the
function of the mononuclear phagocyte system with conflicting results (29,30).
Our goal was to study the in-vitro effects of lipid emulsions containing fatty acids
with different chain length on the production of oxygen radicals by polymorpho-
nuclear leukocytes. These oxygen radicals are important for bacterial killing. Three
parenteral lipid emulsions used in clinical practice were tested: long-chain
triglycerides, a physical mixture of medium-chain and long-chain triglycerides, and
a structured triglyceride emulsion. We studied the production of oxygen radicals by
measuring chemiluminescence of phagocytosing polymorphonuclear leukocytes.
Chemiluminescence is the emission of light by a chemical reaction and occurs
during the production of oxygen radicals (31).
Materials
Volunteers and handling of venous blood samples
Venous blood samples were obtained from 30 healthy volunteers, 15 men and 15
women, aged 22 to 46 years. Their laboratory tests, including blood hemoglobin
and white blood cell count with differential count, and serum total bilirubin,
alkaline phosphatase, aspartate aminotransferase, and fasting cholesterol and
triglycerides were normal. Fasting serum triglycerides ranged from 0.39 to 1.60
mmol/L. The blood was collected into twelve 4 mL-draw sterile vacutainer tubes
(Becton-Dickinson, Rutherford, NJ) containing 4.5 mg lyophilized EDTA(Na2).
Opsonized Zymosan
Zymosan A particles (Sigma Chemical Company, St.Louis, MO), 300 mg, were
washed once in 30 mL phosphate-buffered saline, pH 7.3. For 1 hour, the solution was
treated in a sonificator (Bransonic Ultrasonic Cleaner, Model B-2200 E3, Branson
Cleaning Equipment Company, Shelton, CT) at 47 kHz, to promote equal particle
size. The zymosan particles were opsonized with 30 mL of serum from one donor
with blood group antigen AB, during 60 minutes at 37 0C. Then the particles were
washed three times with phosphate-buffered saline, 4 0C, and centrifuged at 200g for
10 minutes. The pellet of zymosan particles was suspended in 30 mL of Hank's
Balanced Salt Solution without phenol red (Life Technologies, Paisley, Scotland) to a
final concentration of 10 g/L and stored in portions of 1.4 mL at -70 0C.
Luminol solution
Luminol (Sigma Chemical Company) was dissolved in dimethyl sulphoxide (Sigma
Chemical Company) at a concentration of 10-2 M. Before use, the stock solution
was further diluted to a concentration of 2 x 10-5 M in Hank's Balanced Salt
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Solution without phenol red. To this solution, bovine serum albumin (Sigma
Chemical Company) was added, 20 g/L, to prevent cell aggregation.
Lipid emulsions
In experiment 1 and 2, we studied the effect of lipid emulsions on leukocyte function.
We tested three lipid emulsions: a long-chain triglyceride emulsion (Intralipid;
Fresenius-Kabi, Stockholm, Sweden); a physical mixture of medium-chain and long-
chain triglycerides (Lipofundin MCT/LCT; B. Braun Melsungen AG, Melsungen,
Germany); and a structured triglyceride emulsion (Structolipid, Fresenius-Kabi) (Fig.
1, Table I). The weight ratio of long-chain to medium-chain fatty acids is 50% to 50%
in the physical mixture and 64% to 36% in the structured triglyceride emulsion.
These three lipid emulsions have egg yolk phospholipids as the emulsifying agent.
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Table I. Composition and characteristics of the long-chain triglyceride (TG)
emulsion (Intralipid), the physical mixture of medium- and long-chain triglycerides
(Lipofundin MCT/LCT), and the structured triglyceride emulsion (Structolipid).
Composition and Long-chain Physical Structured
characteristics TG mixture TG
Fractionated soy bean oil (g/L) 200 100 0
Medium-chain triglycerides (g/L) 0 100  0  
Structured triglycerides (g/L) 0 0  200    
Mean molecular weight of triglycerides 865 634   683   
Fractionated egg phospholipids (g/L) 12 12 12
Glycerol (USP) (g/L) 22.0 25.0 22.5 
Water for injection ad (mL) 1000 1000   1000   
pH 8 8 6.5-8.5
Osmolality (mOsm/kg water) 350 380 350
Energy content (kcal/L) 2000 1936 1960
Fatty acids, % by weight
Caprylic acid (C8:0) 0 26 27
Capric acid (C10:0) 0 20 10
Palmitic acid (C16:0) 13 7 7
Stearic acid (C18:0) 4 2.5 3
Oleic acid (C18:1) 22 13 13
Linoleic acid (C18:2ω6) 52 27 33
Alpha-linolenic acid (C18:3ω3)   8 3.5 5
Other 1 1 2
In experiment 3 we studied the influence of the emulsifier in the lipid emulsions on
leukocyte function. Three long-chain triglyceride emulsions were tested. Intralipid
and Emulsan (both produced by Fresenius-Kabi) have egg yolk phospholipids as
the emulsifying agent, whereas Lipofundin S (B. Braun Melsungen AG) uses
soybean phospholipids.
All these lipid emulsions used in parenteral nutrition are sterile and pyrogen-free.
Isolation of polymorphonuclear leukocytes
Venous blood was mixed 1:1 with phosphate-buffered saline. Polymorphonuclear
leukocytes were isolated by density gradient centrifugation, using a Percoll gradient
(Percoll, Pharmacia, Uppsala, Sweden], at 500g for 20 minutes. To prevent cell
aggregation, isolation was done at 4 0C and the cells were suspended in phosphate-
buffered saline, containing 1 g gelatin per liter (Bacto-Gelatin, Difco Laboratories,
Detroit, MI). After centrifugation at 500g for 5 minutes, the pellet was resuspended
in ammonium chloride solution (8 g/L), pH 7.4, and contaminating erythrocytes
were lysed for 10 minutes at 4 0C. The cells were then centrifuged at 500g for 5
minutes and the pellet washed once in phosphate-buffered saline containing 
gelatin. The number of cells was counted in a cell counter (Coulter Counter ZM,
Coulter Electronics Nederland, Mijdrecht, The Netherlands) and the suspension
adjusted to a final concentration of 5 x 10 9 per liter with phospate-buffered saline
containing gelatin. At random Cytospin preparations (Shandon, Astmoor, United
Kingdom) demonstrated a contamination of polymorphonuclear leukocytes by
other cells of less than 10 %.
Incubation of the polymorphonuclear leukocytes with the lipid emulsions
One-milliliter samples of polymorphonuclear leukocyte suspension were incubated
for 30 minutes at 37 0C with lipid emulsion. Suspensions of polymorphonuclear
leukocytes in phosphate-buffered saline with gelatin served as a control. During
incubation, the suspensions were continuously mixed. After incubation with the
lipids, the polymorphonuclear leukocyte suspensions were washed twice in
phosphate-buffered saline with gelatin, 4 0C and centrifuged for 5 minutes at 500g.
The pellets were resuspended in 1 mL of phosphate-buffered saline with gelatin at
room temperature and stored for 45 minutes. The number of cells was counted in
the cell counter and the suspensions adjusted to a final concentration of 2 x 10 9 per
liter. With trypan blue (0.4 % in 0.85 % saline, Flow Laboratories Inc, McLean,
VA), the percentage of viable cells in these suspensions was greater than 95 %. 
Measurement of chemiluminescence
The reaction mixtures consisted of 0.2 mL polymorphonuclear leukocyte
suspension, 0.1 mL opsonized zymosan, and 0.7 mL Luminol in Hank's Balanced
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Salt Solution. Therefore the concentration of polymorphonuclear leukocytes in the
reaction mixture was 0.4 x 109 per milliliter and the concentration of opsonized
zymosan in the reaction mixture was 1 mg/mL. Blanks of 0.2 mL phosphate-
buffered saline with gelatin, 0.1 mL opsonized zymosan, and 0.7 mL Luminol were
measured simultaneously. The mixtures were prepared in disposable polystyrene
cuvettes. Chemiluminescence was measured with an automatic photoluminometer
(LKB Wallac Luminometer 1251, Wallac Oy, Turku, Finland), at 37 0C and
recorded as millivolts (mV). The computer calculated the peak light emission (peak
height, mV), the time until the peak of the light emission was reached (peak time,
s), and the total amount of light emitted during the first 100 minutes (mVs).
Statistical analysis
Wilcoxon signed-rank test was applied to test the differences between the three
lipids, and the differences of each lipid with respect to the control (no lipid 
emulsion). Bonferroni correction was used to determine significance: significance
was reached when the p-value was smaller than .0166. The parameters were peak
height, peak time, and the amount of light emitted. 
Experiments
Experiment 1 
Polymorphonuclear leukocytes were preincubated with long-chain triglycerides
(Intralipid), a physical mixture of medium-chain and long-chain triglycerides
(Lipofundin MCT/LCT), or structured triglycerides (Structolipid) in
supraphysiologic concentrations of 25 mmol/L, 50 mmol/L, or 100 mmol/L. 
Experiment 2
Polymorphonuclear leukocytes were preincubated with the same three lipid
emulsions as in experiment 1, but now physiologic concentrations were used of 1.25
mmol/L, 2.50 mmol/L, or 5.00 mmol/L. These physiologic concentrations are
obtained in clinical practice during the treatment of patients with TPN (32).
Experiment 3 
We investigated the role of the emulsifier. We tested three long-chain triglyceride
emulsions, which contain various emulsifiers: Lipofundin S, Intralipid or Emulsan,
in one physiologic concentration of 1.00 mmol/L. Intralipid and Emulsan use egg
yolk phospholipids as emulsifying agent, whereas Lipofundin S uses soybean
phospholipids.
All experiments 
In all three experiments, samples that were preincubated without lipid emulsion
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were used as control. In each of the three experiments, polymorphonuclear
leukocytes from 10 volunteers were tested on 10 different days.
Results
Experiment 1
In all of the supraphysiologic dosages of lipid emulsions, phagocytosing
polymorphonuclear leukocytes preincubated with the physical mixture of medium-
chain and long-chain triglycerides showed a different pattern of chemilu-
minescence compared with preincubation with long-chain triglycerides, structured
triglycerides, or controls (Table II). The production of oxygen radicals was faster 
(p < .005) and reached a higher peak height (p < .005 vs. long-chain triglycerides or
structured triglycerides; p < .02 vs. controls). Furthermore, the overall production
of oxygen radicals was significantly lower with the physical mixture of medium-
chain and long-chain triglycerides (p < .02) or long-chain triglycerides (p < .005)
compared with controls. With structured triglycerides, a significant difference was
not reached. The production of oxygen radicals was faster with all three lipid
emulsions compared with controls, although with long-chain triglycerides or
structured triglycerides the difference was not significant. Chemiluminescence
results (peak height, peak time and overall production of reactive oxygen
metabolites) with long-chain triglycerides and structured triglycerides were equal.
Results with 25 mmol/L, 50 mmol/L, or 100 mmol/L of lipid emulsion did not
differ and so these results were pooled.
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Table II Chemiluminescence by phagocytosing polymorphonuclear leukocytes,
preincubated with various lipid emulsions in supraphysiologic dosages (long-chain
triglycerides, physical mixture of medium- and long-chain triglycerides, or
structured triglycerides versus controls)§.
Controls
Peak Peak Overall
height time production
(mV) (s) (Vs)
Long-chain triglycerides -3 ± 3 -97 ± 88 -23 ± 6**
Physical mixture MCT/LCT +12 ± 3* -618 ± 117** -38 ± 12*
Structured triglycerides -1 ± 2 -52 ± 47   -12 ± 7
§Polymorphonuclear leukocytes of 10 volunteers were measured. Supraphysiologic dosages of
lipid emulsion were 25 mmol/L, 50 mmol/L, or 100 mmol/L. Results with the three
concentrations did not differ and so these results were pooled.
* p < .02 and ** p < .005, using Wilcoxon signed-rank test.
Experiment 2  
In physiologic dosages of lipid emulsions, the same different pattern of
chemiluminescence was observed with phagocytosing polymorphonuclear
leukocytes preincubated with the physical mixture of medium-chain and long-
chain triglycerides compared with preincubation with long-chain triglycerides,
structured triglycerides, or controls (Table III). Again, the production of oxygen
radicals was faster (p < .005) and reached a higher peak height (p < .005) vs. long-
chain triglycerides or structured triglycerides (Fig. 2). Only in physiologic dosages
was the peak height with the physical mixture of medium-chain and long-chain
triglycerides increased, although not significantly compared with controls. Again,
the overall production of oxygen radicals was significantly lower with the physical
mixture of medium-chain and long-chain triglycerides (p < .005), the long-chain
triglycerides (p < .02) or the structured triglycerides (p < .02), compared with
controls. In supraphysiologic dosages, the production of oxygen radicals was faster
with all three lipid emulsions compared with controls (Table II). However, in
physiologic dosages, the production of oxygen radicals was only faster with the
physical mixture (p < .005) and slower with long-chain triglycerides (p < .005) or
the structured triglycerides (p < .005). Chemiluminescence results with long-chain
triglycerides and structured triglycerides were again equal. Results with 1.25
mmol/L, 2.50 mmol/L, or 5.00 mmol/L of lipid emulsion did not differ and so these
results were pooled.
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Table III. Chemiluminescence by phagocytosing polymorphonuclear leukocytes,
preincubated with various lipid emulsions in physiologic dosages (long-chain
triglycerides, physical mixture of medium- and long-chain triglycerides, or
structured triglycerides versus controls)§.
Controls 
Peak Peak Overall
height time production
(mV) (s) (Vs)
Long-chain triglycerides -18 ± 4** +186 ± 21** -29 ± 9*
Physical mixture MCT/LCT + 7 ± 4 -322 ± 28** -49 ± 10**
Structured triglycerides -15 ± 3** +144 ± 34**   -30 ± 9*
§Polymorphonuclear leukocytes of 10 volunteers were measured. Physiologic dosages of lipid
emulsion were 1.25 mmol/L, 2.50 mmol/L, or 5.00 mmol/L. Results with the three
concentrations did not differ and so these results were pooled.
* p < .02 and ** p < .005, using Wilcoxon signed-rank test.
Experiment 3 
There were no differences in production of oxygen radicals between the three long-
chain triglyceride emulsions Lipofundin S, Intralipid, or Emulsan (results not
shown). These lipid emulsions differ in emulsifier: Lipofundin S uses soybean
phopholipids and Intralipid and Emulsan use egg yolk phospholipids.
Discussion
Polymorphonuclear leukocytes preincubated with a physical mixture of medium-
chain and long-chain triglycerides differed in pattern of light emission, compared
with preincubation with long-chain triglycerides, structured triglycerides or
controls. This different pattern was seen with supraphysiologic and physiologic
dosages of lipid emulsions, and was characterized by higher peak height and shorter
peak time of light emission. This indicates, that phagocytosing polymorphonuclear
leukocytes preincubated with the physical mixture produced oxygen radicals faster,
resulting in higher peak levels of oxygen radicals. The clinical consequences in
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Figure 2. Luminol-enhanced chemiluminescence of zymosan-stimulated phagocytosis
by polymorphonuclear leukocytes of one volunteer. The polymorphonuclear leukocytes
were preincubated with lipid emulsion (1.00 mmol/L) or without lipid emulsion (solid,
bold line). Preincubation with a physical mixture of medium-chain and long-chain
triglycerides (broken line) results in a different pattern of chemiluminescence compared
with preincubation with long-chain triglycerides (solid, not bold line) or structured
triglycerides (dotted line), characterized by a faster production of oxygen radicals and
higher peak levels of oxygen radicals.
patients could be that this pattern of oxygen radical production is detrimental when
oxygen radicals either play a pathogenic role (as in multiple organ failure) or a
beneficial one as when rapid phagocytosis and killing of bacteria is needed.
Preincubation with long-chain triglycerides, the physical mixture or structured
triglycerides reduced the overall production of oxygen radicals, compared with
controls without lipid emulsion; only with structured triglycerides in high dosages
significance was not reached. Almost all of the studies on the influence of lipid
emulsions on oxygen radicals have used only long-chain triglyceride emulsions.
These studies also reported a depressed production of oxygen radicals (9,13-15). Only
one study has investigated the effect of a physical mixture and showed a depressed
production of oxygen radicals (20). The different pattern of chemiluminescence with
a physical mixture was not described earlier. Only two in-vivo infusion studies in
humans have been performed on oxygen radical production, both with long-chain
triglycerides. These two studies confirmed a depression of oxygen radical production
in humans after infusion of long-chain triglycerides (14,16).
The most likely explanation for differences in oxygen radical production between
lipid emulsions is the difference in triglyceride composition. Another possible
factor that could be of influence is the emulsifier. The emulsifier is a component of
every parenteral lipid emulsion and consists of phospholipids. We studied the effect
of three long-chain triglyceride emulsions with various emulsifiers. No differences
in oxygen radical production between these emulsions were observed. This
indicates that the differences in oxygen radical production are caused by differences
in triglycerides. Other investigations also indicate the fatty acid composition of the
triglycerides as a cause of changes in polymorphonuclear leukocyte function. The
long-chain fatty acids, palmitic and oleic acid, present in parenteral lipid emulsions,
caused depression of chemotaxis and phagocytosis by polymorphonuclear
leukocytes (33). One study described a synergistic stimulatory action of oleic acid
and the cytokine tumor necrosis factor-α on the production of oxygen radicals (34).
Functional changes of leukocytes were accompanied by morphological alterations
on electron microscopic examination (33), with cytoplasmic lipid droplets, and
dilations of endoplasmic reticulum with degenerative degranulated cytoplasmic
areas. Indeed, after infusion of long-chain triglycerides, cytoplasmic lipid droplets
in the polymorphonuclear leukocytes, surrounded by a bilayer membrane were
observed (14). This suggests engulfment of lipid particles, which reduces the cell
surface and may cause impaired motility and phagocytosis (14). Also, it was
hypothesized that decreased deformability of the cells (33), alterations in lipid
composition of the cell membrane, changes in membrane fluidity (9), degranula-
tion, and cell injury cause impaired polymorphonuclear function (33). Finally, fatty
acids, especially the polyunsaturated essential fatty acids, have a direct
immunomodulatory effect (34).
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In conclusion, a physical mixture of medium-chain and long-chain triglycerides has
a different effect on the production of oxygen radicals by phagocytosing
polymorphonuclear leukocytes compared with a long-chain or a structured
triglyceride emulsion, causing higher peak levels and a faster production of oxygen
radicals. This can potentially be detrimental when oxygen radicals play a
pathogenic role or beneficial when rapid phagocytosis is needed. The overall
production of oxygen radicals was decreased with all three lipid emulsions, which
may explain immunosuppression by parenteral lipid emulsions.
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Introduction
Over fifteen years ago animal studies already indicated that structured triglycerides
have beneficial effects on nitrogen balance. In rat experiments it was demonstrated
that structured triglycerides improved nitrogen retention and body weight
compared to lipid emulsions containing medium-chain triglycerides, long-chain
triglycerides or physical mixtures (1,2,3).
Structured triglycerides versus long-chain triglycerides
The first clinical studies on structured triglycerides compared structured
triglycerides with long-chain triglyceride emulsions. Sandström et al. published the
first clinical trial on structured triglycerides in 1993 (4). They infused lipid
emulsions containing structured triglycerides or long-chain triglycerides in post-
operative patients and demonstrated that structured triglycerides were safe and
well-tolerated.
Two years later the same group studied structured triglycerides again in surgical
patients. Patients were randomized to receive structured triglycerides for one day
followed by long-chain triglycerides the next day or vice versa for a period of six
days. In part one of the study patients were provided 1.0 g fat/kg/day in the
presence of 80 % of basal energy expenditure as non-protein calories; in part 2 they
received 1.5 g fat/kg/day and 120 % of basal energy expenditure as non-protein
calories (5). Structured triglycerides were well-tolerated and increased lipid
oxidation rate. In both studies no differences between the two groups were seen
concerning nitrogen balance. In the structured triglyceride group, 
β-hydroxybutyrate concentrations were higher.
Bellantone et al. compared structured triglycerides and long-chain triglycerides in
terms of nitrogen balance in patients with colorectal surgery (6). They also
demonstrated safety and tolerability of structured triglycerides. The cumulative
nitrogen balance on day 5 was significantly better in the structured triglyceride
group (10.7 ± 10.5 vs. 6.5 ± 17.9 g nitrogen; p=0.05).
A more recent study was published by Lindgren et al (7). Thirty Intensive Care
patients with pancreatitis, ARDS or peritonitis were included and randomized to
receive either structured triglycerides or a long-chain triglyceride emulsion.
Patients in the structured triglyceride group had a significantly better nitrogen
balance compared to the long-chain triglyceride group after 3 days (–0.7 ± -6.0 vs.
–16.5 ± -3.9 g nitrogen/day), but not after 5 days. Probably the reason for the loss
of significance is the loss of patients during this study.
A safety study with patients on long-term home parenteral nutrition has also been
carried out (8). In this double blind controlled cross-over trial, patients with
Crohn’s disease or a short bowel syndrome received for four weeks a long-chain
triglyceride emulsion and the following four weeks an emulsion containing
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structured triglyceride, and vice versa. There were no differences in liver and kidney
function, plasma lipids, free fatty acids and 3-OH fatty acids. Two patients showed
liver function disorders during the administration of the long-chain triglyceride
emulsion, which normalized after switch to structured triglycerides. 
Structured triglycerides versus physical mixture
Even more interesting as the comparison of structured triglycerides with long-chain
triglycerides, is the comparison of structured triglycerides with a physical mixture
of medium-chain and long-chain triglycerides, because in animal studies it has been
shown that structured triglycerides are even better than physical mixtures with
regard to various effects. We carried out a clinical trial, which was designed as a
randomized, double-blind parallel study in 25 surgical patients, after elective
implantation of an aortic prosthesis (9). The cumulative nitrogen balance after 5
days was significant better in the structured triglyceride group (-8  ± 2 g vs. –21 ±
4 g nitrogen over 5 days; p = .015).
Chambrier et al. included 40 surgical patients and provided 50 % of the non-protein
calories as lipids (10). The endpoints were the cumulative nitrogen balance and 3-
methylhistidine excretion. No different effects of the two lipid emulsions on any of
the endpoints could be demonstrated.
Overview structured triglycerides and nitrogen balance
Table I summarizes the results of the fully published clinical trials on structured
triglycerides and nitrogen balance. In two of the four fully published trials
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Table I. Summary of the published controlled clinical trials on nitrogen balance with
structured triglycerides (STG) versus long-chain triglycerides (LCT), or versus a
physical mixture of medium-chain and long-chain triglycerides (MCT/LCT).
Patients, number Effect
STG vs. LCT
Lindgren on ICU with sepsis or significant better nitrogen  
multiple injury, 30 balance, 3 days
Bellantone colorectal surgery significant better nitrogen
19 balance, 5 days
Sandström, 1993 elective surgery no difference in nitrogen 
20 balance/day, 5 to 7 days
Sandström, 1995 elective surgery no difference in nitrogen 
19 + 18, cross-over balance/day, 2 x 3 days
STG vs. MCT/LCT
Chambrier abdominal surgery no difference in nitrogen
40 balance, 7 days
Kruimel major vascular surgery significant better nitrogen 
19 balance, 5 days
comparing structured triglycerides with long-chain triglycerides the nitrogen
balance was better in the structured triglycerides group. In the second study of
Sandström the results can be explained by the study design. In this study the type
of lipid emulsion was switched every day, which makes it difficult to reach
significant differences between the groups.
In the two fully published papers comparing structured triglycerides with a
physical mixture, our study demonstrated improvement of nitrogen balance. We
provided 30 % of the calories by the lipid emulsions. In the study by Chambrier
50% of the calories were provided by the lipid emulsions. The nitrogen balance in
their study was slightly positive in the structured triglycerides group, but they did
not find a significant difference between the groups. The differences in results
between the two trials could be explained by the differences in study design.
Hypotheses to explain the effects of the various lipid emulsions
In our study we assessed serum triglycerides, plasma medium-chain free fatty acids
and β-hydroxybutyrate. Triglycerides are hydrolyzed by lipoprotein lipase to free
fatty acids, monoglycerides and glycerol, which enter the mitochondria and are
oxidized. In case the oxidative system is overloaded, only partial oxidation of the
fatty acids takes place and intermediates (acetyl-CoA) are converted to 
β-hydroxybutyrate. In our trial on the first post-operative day, serum triglyceride
concentrations were almost doubled
during the 6-hour period of lipid
infusion in the physical mixture group
compared with the structured
triglycerides group (Fig. 1). The same
picture emerged for the plasma
medium-chain free fatty acid
concentrations (Fig. 2). Both could
not be explained by the slightly higher
amount of triglycerides (1.08 times)
and medium-chain fatty acids (1.25
times), on a molar base, in the
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Figure 1. Concentrations of serum
triglycerides during a six hour
administration of structured trigly-
cerides (STG) and a physical mixture of
medium-chain and long-chain
triglycerides (MCT/LCT) (difference in
change 1.10 mmol/L, 95 % confidence
interval 0.70 to 1.50, p< 0.00005).
physical mixture group. Contrarily, the concentrations of plasma 
β-hydroxybutyrate were significantly higher in the structured triglyceride group
(Fig. 3). These concentrations did not reach toxic levels.    
These results indicates a faster clearance of structured triglycerides, a faster uptake
by the cells and a high oxidation rate, because the increase in β-hydroxybutyrate
points to the hypothesis that the β-oxidative system has reached the maximum
capacity. The high oxidation rate has been demonstrated before. Nordenström et
al., who administered structured triglycerides and a physical mixture to healthy
volunteers, have shown a faster oxidation with structured triglycerides (11). Thörne
et al. demonstrated, in an experimental system using the clamp technique, that
structured triglycerides were cleared 36 % faster than long-chain triglycerides (12).
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Figure 2. Concentrations of plasma
medium-chain free fatty acids during a
six hour administration of structured
triglycerides (STG) and a physical
mixture of medium-chain and long-chain
triglycerides (MCT/LCT) (difference in
change 145 µmol/L, 95 % confidence
interval 99 to 161, p< 0.00005). 
Figure 3. Concentrations of plasma β-
hydroxybutyrate during a six hour
administration of structured
triglycerides (STG) and a physical
mixture of medium-chain and long-
chain triglycerides (MCT/LCT)
(difference in change 35 µmol/L, 95 %
confidence interval 3 to 66, p< 0.05).
Hultin et al. investigated in an in-vitro model the effect of lipoprotein lipase on
long-chain triglycerides (LLL), medium-chain triglycerides (MMM) or structured
triglycerides, in which long-chain fatty acids were attached to the middle position
in the triglyceride molecule (MLM) (13). They found a fast hydrolysis of structured
triglycerides (MLM) with the production of free medium-chain fatty acids and
long-chain monoglycerides. The cells took up the long-chain monoglycerides very
rapidly, probably because of their lipophilic nature. This could be at least in part the
reason for structured triglycerides being hydrolyzed and taken up faster than long-
chain triglycerides or physical mixtures. Because only part of the structured
triglycerides in our study were structured as MLM this mechanism can not
completely explain the highly significant lower triglyceride and medium-chain fatty
acid concentrations during the structured triglyceride administration. 
Also, the simple fact that more lipid is taken up by the cells and oxidized faster
cannot completely account for the better nitrogen balance with structured
triglycerides. In our study we found a significant increase of β-hydroxybutyrate
concentrations, a ketone body. Ketone bodies may influence the metabolism by
induction of  insulin release (14). Insulin has a positive effect on the nitrogen
balance. Another explanation could be the effect of ketone bodies as an alternative
energy source for certain organs.
Magnusson Borg et al. investigated the influence of structured triglycerides on
protein metabolism (15). Thirty four partially hepatectomized rats were given long-
chain triglycerides or structured triglycerides. The fat emulsions were each
provided with or without glucose to measure the effect on acetyl-CoA. Protein
synthesis was assessed by 14C-phenylalanine incorporation and protein oxidation
was measured by the 14C-leucine oxidation rate. Weight loss was lower in the
structured triglycerides group. Protein oxidation was not influenced by the lipid
emulsions, but was increased in both groups without glucose administration. In
both groups with structured triglycerides the protein synthesis was significantly
higher compared with the long-chain triglyceride groups, indicating that structured
triglycerides improve protein synthesis and has no influence on protein breakdown. 
Conclusion
Parenteral structured triglycerides improve nitrogen balance in most of the studies,
and are utilized faster and converted to ketone bodies. The improvement in
nitrogen balance could in part be explained by the effect of lipoprotein lipase,
resulting in a higher oxidation rate. Also the higher production of ketone bodies
increase insuline levels, which may preserve protein mass. This preservation is
mainly due to improvement of protein synthesis. Moreover, ketone bodies are an
important energy source for various organs. Another explanation for the effect on
nitrogen balance could be that structured triglycerides or ketone bodies, by a direct
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effect, improve nitrogen balance by interference in the metabolic pathways. 
More human data on the influence of structured triglycerides on protein
metabolism and triglyceride clearance, and on the effects of  the various
compositions of structured triglycerides on lipoprotein lipase, are needed. Further
human studies are necessary, particularly dose-response studies, bearing in mind
the study of Chambrier (10), where the main difference to our own study was the
higher lipid dose. 
Studies with clinical endpoints like complications and survival rates are not
published. The present studies do not indicate detrimental effects on morbidity and
mortality rates, and may indicate positive effects by the effects on the metabolic
pathways. Studies with real structured triglycerides, in which every fatty acid in
each position within the triglyceride molecule is determined, are of great
importance.
87
REFERENCES
1. Maiz A, Yamazaki K, Sobrado J, et al: Protein metabolism during total parenteral (TPN)
in injured rats using medium-chain triglycerides. Metabolism 33:901-909, 1984.  
2. Mok KT, Maiz A, Yamazaki K, et al: Structured medium-chain and long-chain
triglyceride emulsions are superior to physical mixtures in sparing body protein in the
burned rat. Metabolism 33:910-915, 1984.
3. DeMichele SJ, Karlstad MD, Bistrian BR, et al: Enteral nutrition with structured lipid:
effect on protein metabolism in thermal injury. Am J Clin Nutr 50:1295-1302, 1989.
4. Sandström R, Hyltander A, Körner U, et al: Structured triglycerides to postoperative
patients: a safety and tolerance study. JPEN 17:153-157, 1993.
5. Sandström R, Hyltander A, Körner U, et al: Structured triglycerides were well tolerated
and induced increased whole body fat oxidation compared with long-chain triglycerides
in postoperative patients. JPEN 19:381-386, 1995.
6. Bellantone R, Bossola M, Carriero C, et al: Structured versus long-chain triglycerides: a
safety, tolerance, and efficacy randomized study in colorectal surgical patients. JPEN
23(3):123-127, 1999.
7. Lindgren BF, Ruokonen E, Magnusson-Borg K, et al: Nitrogen sparing effect of
structured triglycerides containing both medium- and long-chain fatty acids in critically
ill patients; a double blind randomized controlled trial. Clin Nutr 20(1):43-48, 2001.
8. Rubin M, Moser A, Vaserberg N, et al: Structured triacylglycerol emulsion, containing
both medium- and long-chain fatty acids, in long-term home parenteral nutrition: a
double-blind randomized cross-over study. Nutrition 16:95-100, 2000.
9. Kruimel JW, Naber TH, van der Vliet JA, et al: Parenteral structured triglyceride
emulsion improves nitrogen balance and is cleared faster from the blood in moderately
catabolic patients. JPEN 25:237-244, 2001.
10. Chambrier C, Guiraud M, Gibault JP, et al: Medium- and long-chain triacylglycerols in
postoperative patients: structured lipids versus a physical mixture. Nutrition 15(4):274-
277, 1999.
11. Nordenström J, Thörne A, Olivecrona T. Metabolic effects of infusion of a structured-
triglyceride emulsion in healthy subjects. Nutrition 11:269-274, 1995.
12. Thörne A, Nordenström J, Carneheim C, et al: Higher plasma elimination rate of
structured triglycerides vs. LCT determined by hypertriglyceridaemic clamp technique
[Abstract]. Clinical Nutrition 12(suppl 2):3, 1993.
13. Hultin M, Müllertz A, Zundel MA, et al: Metabolism of emulsions containing medium-
and long-chain triglycerides or interesterified triglycerides. J Lipid Res 35:1850-1860,
1994.
14. Miles JM, Nissen SL, Rizza RA, et al: Failure of infused beta-hydroxybutyrate to
decrease proteolysis in man. Diabetes 32:197-205, 1983.
15. Magnusson Borg IK, Sandberg LG, Wennberg AK et al: Effects of a lipid emulsion
containing medium-chain fatty acids and long-chain fatty acids on protein and energy
metabolism in partially hepatectomized rats. Clin Nutr 14:23-28, 1995.
88
Chapter 10
SUMMARY
Total parenteral nutrition is complete nutrition intravenously administered to
patients, incapable of adequate food absorption. Total parenteral nutrition consists
of lipids, carbohydrates, amino acids, minerals, trace elements and vitamins. This
type of nutrition is necessary in the treatment of post-operative patients, patients
on Intensive Care Units and patients with gastrointestinal diseases, in case the
gastrointestinal tract is temporarily or permanently incapable of adequate food
absorption.
A special group of patients with longstanding malabsorption or dysmotility of the
small bowel is totally dependent on home parenteral nutrition for adequate intake
of calories and nutrients. The most common cause of malabsorption in this group
is the short bowel syndrome after partial small bowel resection.  
The aim of this study was to investigate safety, tolerance, and effects on nitrogen
balance and immunology of structured triglycerides, a newly synthesized
parenteral lipid emulsion (Chapter 1). A positive effect of lipid emulsions on
nitrogen balance suggests conservation of muscle mass and organ function,
especially important in severe catabolic patients. A modulatory effect of lipid
emulsions on immunological functions may have implications for patients, who
often have infections and immunological disorders or undergo surgery, where
wound healing and post-operative infections are important problems. 
The first experiments on the use of parenteral lipid emulsions dated back to 1712,
when William Courten administered intravenously olive oil to dogs (Chapter 2). It
lasted until 1961, when Schuberth and Wretlind, by trial and error, produced the
first intravenous lipid emulsion of soybean oil with egg yolk phospholipids as
emulsifier, which proved to be not toxic. This first intravenous lipid emulsion was
a long-chain triglyceride emulsion, containing mainly triglycerides with only long-
chain fatty acids attached to the glycerol backbone. Long-chain triglycerides are
hydrolyzed by lipoprotein lipase to free fatty acids and glycerol. Free fatty acids are
taken up by the cells and oxidized in the mitochondria. The uptake of long-chain
fatty acids in the mitochondria is carnitine-dependent, but the uptake of medium-
chain fatty acids does not require carnitine. This is important, because carnitine
levels are decreased in critically ill patients.   
In the 1980's efforts were made to improve these lipid emulsion: physical mixtures
of medium-chain triglycerides and long-chain triglycerides were introduced. In
animals medium-chain triglycerides had metabolic benefits compared with long-
chain triglycerides; they improved nitrogen balance, were metabolized more
rapidly and stored less in tissues, and were oxidized mainly independently of
carnitine.  
However, intravenously infused medium-chain triglycerides are metabolized to
medium-chain free fatty acids, which may be toxic in higher dose mainly due to
higher production of ketone bodies resulting in metabolic acidosis. To improve the
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safety of the physical mixtures, structured triglycerides were synthesized 
(Chapter 3). Structured triglycerides consist of triglycerides where the medium-
chain and long-chain fatty acids are at random attached to the same glycerol
backbone. With the use of structured triglycerides plasma levels of medium-chain
free fatty acids were lower in healthy volunteers compared with a physical mixture
of medium-chain and long-chain triglycerides; structured triglycerides were cleared
faster from the blood compared with a physical mixture. No data were available on
plasma levels of medium-chain free fatty acids and serum 
levels of triglycerides in patients on structured triglycerides, compared with a
physical mixture.
Moreover, in animals the structured triglyceride emulsion improved nitrogen
balance, increased hepatic protein synthesis and serum albumin levels, and decreased
leucine oxidation compared with emulsions of a physical mixture of medium-chain
and long-chain triglycerides. Again no data were available on nitrogen balance in
patients on structured triglycerides, compared with a physical mixture. 
On the immunological effects of intravenous lipid emulsions much controversy
exists (Chapter 4). Some in-vitro and in-vivo studies showed impairment of
leukocyte function by long-chain triglyceride emulsions. In other studies this could
not be confirmed. Studies on the effects of lipid emulsions containing medium-
chain triglycerides are scarce, but there are indications of a different effect of these
lipids.   
We studied in a randomized, double-blind parallel trial on 25 patients, the effects on
nitrogen balance of structured triglycerides compared with a physical mixture of
medium-chain and long-chain triglycerides, as part of 5 days post-operative
parenteral feeding in moderately catabolic patients (Chapter 5). In the patients who
completed the study, the mean cumulative nitrogen balance over the first 5 post-
operative days was significantly better in the structured triglyceride group (-8 ± 2 g
in 10 patients on the structured triglyceride emulsion and -21 ± 4 g in 9 patients on
the emulsion of the physical mixture of medium- and long-chain triglycerides, p =
.015). On the first post-operative day serum triglyceride and plasma medium-chain
free fatty acid levels increased less during administration of the structured
triglyceride emulsion compared with the physical mixture emulsion. Therefore, the
parenteral structured triglyceride emulsion improved the nitrogen balance and was
cleared faster from the blood, compared with the physical mixture. No difference
in safety and tolerance between the two emulsions was observed.
In 13 patients of the trial the phagocytosing capacity of the mononuclear phagocyte
system, determined by the clearance of 99m Technetium-Sulfur-colloid from the
blood, was measured (Chapter 6). This method represents the clearance of bacteria
from the blood by the mononuclear phagocyte system. Seven patients received 
an emulsion of a physical mixture of medium-chain and long-chain 
91
triglycerides and 6 patients a structured triglyceride emulsion. The 
99m Technetium-Sulfur-colloid clearance from the blood was the same in the two
study groups, before the administration of lipid emulsion, as well as after 5 days of
treatment, and did not change during treatment. Therefore, parenteral lipid
emulsions with medium-chain fatty acids did not impair the clearance of 
99m Technetium-Sulfur-colloid by the mononuclear phagocyte system. In this respect
there was no difference between the effects of an emulsion of a physical mixture of
medium-chain and long-chain triglycerides and a structured triglyceride emulsion. 
We also wanted to study the effect of parenteral lipid emulsions on cytokines in our
trial (Chapter 7). No differences were observed. The effect of surgery
overwhelmed the effect of nutrition, making conclusions on the effect of the lipid
emulsions on cytokine production impossible. Instead the relation between the
immune and neuroendocrine response during surgery was studied in 18 patients
and we demonstrated a depression of circulating pro-inflammatory IL-1ß and an
increase of circulating anti-inflammatory IL-1ra during surgical stress. The ex-vivo
production of IL-1ß and TNF-α was suppressed, indicating a downregulation of
the production of these cytokines. This paralleled the hormonal reaction with high
ADH and ACTH, but not of cortisol, suggesting that glucocorticoid is not the key-
factor in downregulation of production and release of pro-inflammatory cytokines. 
Finally, in an in-vitro study polymorphonuclear leukocytes of volunteers were pre-
incubated with parenteral lipid emulsions and the influence of these lipid emulsions
on the production of oxygen radicals by the leukocytes was studied by measuring
chemiluminescence (Chapter 8). Stimulated polymorphonuclear leukocytes
preincubated with the physical mixture of medium-chain and long-chain trigly-
cerides showed higher levels of oxygen radicals (p < .005) and faster production of
oxygen radicals (p < .005), compared with polymorphonuclear leukocytes pre-
incubated with long-chain triglycerides or structured triglycerides. Additional
studies indicated that differences in results of various lipid emulsions were not
caused by differences in emulsifier. The overall production of oxygen radicals was
significantly lower after pre-incubation with the three lipid emulsions, compared
with controls without lipid emulsion. Therefore, a physical mixture of medium-
chain and long-chain triglycerides induced faster production of oxygen radicals,
resulting in higher levels of oxygen radicals, compared with long-chain triglycerides
or structured triglycerides. This can be detrimental in case oxygen radicals play a
pathogenic role or beneficial when rapid phagocytosis and killing of bacteria is
needed. The successive studies by Wanten et al. confirmed that the interaction of
medium-chain triglyceride emulsions with immune cells differs quite strongly from
that of emulsions containing long-chain triglycerides or structured triglycerides.
Studies on the clinical relevance of these observations are needed.
In chapter 9 the results of the present studies are positioned between other studies.
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The recently published papers on structured triglycerides are discussed and
hypotheses to explain the difference in nitrogen balance between structured
triglycerides and a physical mixture of medium- and long-chain triglycerides in
moderately catabolic patients are proposed.  
Future
Continuously improvement of the fat emulsions in parenteral nutrition is pursued.
Triglycerides are especially interesting molecules, because they have nutritive, as
well as pharmacological properties. Examples of these pharmacological properties
are effects on the immune system, on platelet aggregation, blood viscosity and on
microvascular permeability. We studied structured triglycerides where the medium-
and long-chain fatty acids are at random attached to positions on the same glycerol
molecule. Real structured triglycerides are synthesized molecules in which on
demand specific fatty acids are attached to a specific position in the glycerol
molecule. This will enables us to make tailor-made fatty acid patterns, adjusted to
the needs of specific patient groups using specific properties of the fatty acids. A
further possibility for the future is the introduction of other useful nutrients like
glutamine, and even drugs, into the structured triglycerides. This will be the
ultimate adaptation of the properties of the infused lipid emulsion to the needs of
the patient: pharmacological parenteral lipid emulsions.
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Chapter 11
SAMENVATTING
Totale parenterale voeding is volwaardige intraveneuze voeding, die toegediend
wordt aan patiënten, die niet in staat zijn om te eten of om voldoende
voedingsstoffen op te nemen uit hun maaltijden of uit vloeibare voeding toegediend
via een slangetje gepositioneerd in het maagdarmstelsel. Totale parenterale voeding
bestaat uit vetten, koolhydraten, aminozuren, mineralen, sporenelementen en
vitamines. Dit soort voeding is noodzakelijk bij de behandeling van postoperatieve
patiënten, patiënten op afdelingen Intensieve Zorgen en patiënten met maag- en
darmziekten, wanneer het maagdarmkanaal tijdelijk of blijvend niet in staat is
voldoende voeding op te nemen.
Een bijzondere groep van patiënten heeft thuis parenterale voeding nodig door
langdurige problemen van malabsorptie of motiliteitsstoornis op het niveau van de
dunne darm. De belangrijkste oorzaak voor malabsorptie in deze groep is het
"short bowel" syndroom, waarbij een deel van de dunne darm door de chirurg
moest worden weggenomen door ziekte.
Het doel van deze studie was om de veiligheid, de eventuele bijwerkingen, en de
effecten op de stikstofbalans en het immunologisch systeem te onderzoeken van
"structured triglycerides", een nieuwe, gesynthetiseerde vorm van parenterale
vetemulsie (Hoofdstuk 1). Een positief effect van vetemulsies op de stikstofbalans
wijst op behoud van spiermassa en orgaanfunctie, wat bijzonder belangrijk is bij
patiënten, bij wie meestal sprake is van eiwitafbraak, dus spierafbraak. Een
verandering  in de functie van het immunologische systeem door vetemulsies kan
eveneens belangrijke gevolgen hebben voor patiënten, die vaak lijden aan infecties
en ziekten van het immuunsysteem, of een operatie hebben ondergaan, waarbij
wondgenezing en postoperatieve infecties juist een belangrijke rol spelen in het
verloop van het herstel.
De eerste, die experimenten uitvoerde met parenterale vetemulsies, was William
Courten, die al in 1712 olijfolie intraveneus toediende aan een hond; de hond
overleed door longproblemen (Hoofdstuk 2). Pas in 1961 werd door de beroemde
Shuberth en Wretlind voor het eerst een veilige intraveneuze vetemulsie voor
patiënten samengesteld, bestaande uit sojaboonolie met als emulgator fosfolipiden
uit eigeel. Deze eerste intraveneuze vetemulsie bestond met name uit  lange-keten
vetten, met triglyceriden opgebouwd uit lange-keten vetzuren verbonden met
glycerol. Vetzuren worden vrijgemaakt uit triglyceriden door splitsing van
triglyceriden in vrije vetzuren en glycerol onder invloed van het enzym
lipoproteine lipase. De vetzuren worden opgenomen door de cel en verbrand in de
mitochondriëen. De opname van lange-keten vetzuren door de mitochondriëen is
afhankelijk van de aanwezigheid van carnitine, in tegenstelling tot de opname van
middellange-keten vetzuren die carnitine-onafhankelijk verloopt. Dit is van belang,
omdat bij ziekte carnitine vaak deficiënt is. 
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In de jaren tachtig werden pogingen gedaan om de lange-keten vetemulsie te
verbeteren: mengsels bestaande uit middellange-keten vetten en lange-keten vetten
werden geïntroduceerd. In dierexperimenten hadden middellange-keten vetten
voordelen boven lange-keten vetten; de stikstofbalans verbeterde, hun afbraak was
sneller en hun opslag in de weefsels minder, en zij konden onafhankelijk van het
carnitinesysteem benut worden.
Intraveneus toegediende middellange-keten vetten worden afgebroken tot
middellange-keten vetzuren en glycerol. Deze middellange-keten vetzuren kunnen
echter toxisch zijn in hogere dosis door vooral een hogere productie van ketonen
waardoor metabole acidose kan ontstaan. Om de veiligheid van de vetemulsies met
mengsels van middellange-keten en lange-keten vetten te verbeteren werden recent
"structured triglycerides" gesynthetiseerd (Hoofdstuk 3). Structured triglycerides
bestaan uit triglyceriden, waarbij middellange-keten en lange-keten vetzuren in
willekeurige volgorde zijn verbonden aan glycerol. Bij gebruik van structured
triglycerides bij gezonde vrijwilligers waren plasma concentraties van middellange-
keten vetzuren lager dan bij het gebruik van de mengsels van middellange-keten en
lange-keten vetten; structured triglycerides werden ook sneller opgenomen uit de
bloedbaan dan deze mengsels. Er waren tot op heden geen gegevens beschikbaar
over plasma concentraties van middellange-keten vetzuren en serum concentraties
van triglyceriden bij behandeling van patiënten met structured triglycerides, in
vergelijking met de mengsels van middellange-keten en lange-keten vetten.
Bovendien werd in dierexperimenten aangetoond, dat structured triglycerides een
verbetering gaf in stikstofbalans, eiwitsynthese in de lever en serum concentratie
van albumine, en een afname van de afbraak van het aminozuur leucine, in
vergelijking met een mengsel van middellange-keten en lange-keten vetten.
Gegevens over de stikstofbalans bij behandeling van patiënten met structured
triglycerides, in vergelijking met een mengsel van middellange-keten en lange-keten
vetten, ontbraken bij de start van ons onderzoek.
Eerdere onderzoeken gaven niet een eenduidig antwoord op de vraag wat het effect
is van intraveneuze vetemulsies op het immunologisch systeem (Hoofdstuk 4).
Enkele onderzoeken waarbij immunologisch actieve cellen (leukocyten) werden
samengebracht met deze vetemulsies in het laboratorium en ook enkele
onderzoeken bij gezonde vrijwilligers en patiënten toonden een nadelig effect aan
van lange-keten vetemulsies op de functie van leukocyten. Andere studies konden
dit echter niet bevestigen. Studies over de effecten van middellange-keten vetten
zijn schaars, maar er zijn aanwijzingen, dat middellange-keten vetten een ander
effect hebben op het immunologisch systeem. 
Wij bestudeerden in een gerandomiseerd, dubbelblind onderzoek met 25 patiënten
de effecten van structured triglycerides op de stikstofbalans, in vergelijking met een
mengsel van middellange-keten en lange-keten vetten, tijdens 5 dagen
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postoperatieve parenterale voeding (Hoofdstuk 5). In de groep patiënten, die de
studie konden afmaken, was de stikstofbalans significant beter, wanneer behandeld
was met structured triglycerides (-8 ± 2 g bij 10 patiënten uit de structured
triglycerides groep en -21 ± 4 g bij 9 patiënten uit de groep behandeld met een
mengsel van middellange-keten en lange-keten vetten, p = .015). Op de eerste
postoperatieve dag stegen serum concentraties van triglyceriden en plasma
concentraties van middellange-keten vetzuren minder tijdens toediening van de
structured triglycerides dan tijdens toediening van het mengsel van middellange-
keten en lange-keten vetten. Geconcludeerd werd dat de parenterale structured
triglycerides emulsie de  stikstofbalans verbeterde en sneller opgenomen werd uit
de bloedbaan dan het mengsel van middellange-keten en lange-keten vetten. Er
werden geen verschillen in het optreden van bijwerkingen geconstateerd tussen
beide patiëntengroepen.
Bij 13 patiënten uit het onderzoek werd de fagocytose-capaciteit van het
mononucleaire fagocyten systeem onderzocht, door de klaring van 99m Technetium-
Sulfur-colloid uit het bloed te meten (Hoofdstuk 6). Fagocytose is het opnemen
van schadelijke deeltjes of micro-organismen door immunologisch actieve cellen,
bijvoorbeeld door cellen uit het mononucleaire fagocyten systeem.  Zeven patiënten
werden behandeld met een mengsel van middellange-keten en lange-keten vetten en
6 patiënten met  structured triglycerides. De 99m Technetium-Sulfur-colloid klaring
uit het bloed was gelijk in de 2 groepen na 5 dagen behandeling en veranderde niet
tijdens de behandeling. Geconcludeerd werd, dat beide parenterale vetemulsies met
middellange-keten vetzuren (het mengsel van middellange-keten en lange-keten
vetten én de structured triglycerides) de functie van het mononucleaire fagocyten
systeem niet nadelig beïnvloedden.
Wij trachtten ook het effect van parenterale vetemulsies op cytokines te bestuderen
in ons patiëntenonderzoek (Hoofdstuk 7). Er werden geen verschillen
geconstateerd. Het onverwachte effect van chirurgie op cytokines bleek dermate
groot, dat het onmogelijk was om modulerende effecten van vetemulsies op
cytokineproductie te detecteren in dit model. In de plaats hiervan bestudeerde wij
de relatie tussen de immuunrespons en de neuroendocriene respons tijdens
chirurgie in 18 patiënten en toonden een onderdrukking aan van het circulerende
pro-inflammatoire IL-1ß en een toename van het circulerende anti-inflammatoire
IL-1ra tijdens chirurgische stress. De ex-vivo productie van IL-1ß en TNF-α was
onderdrukt tijdens chirurgie, wat wees op een downregulatie van de productie van
deze cytokines. Dit liep parallel met de hormonale reactie met een hoog ADH en
ACTH, maar niet met cortisol, wat een aanwijzing vormde, dat glucocorticoïden
geen sleutelrol spelen in de downregulatie van productie en vrijmaking van pro-
inflammatoire cytokines. 
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Tot slot werd een studie verricht, waarbij in het laboratorium polymorfonucleaire
leukocyten (immunologisch actieve cellen) van gezonde vrijwilligers werden
samengebracht met parenterale vetemulsies; de invloed van deze vetemulsies op de
productie van zuurstofradicalen (van belang voor het onschadelijk maken van
micro-organismen) door de leukocyten werd bestudeerd door chemiluminescentie
te meten (Hoofdstuk 8). Gestimuleerde polymorfonucleaire leukocyten
samengebracht met het mengsel van middellange-keten en lange-keten vetten
toonden hogere niveaus van zuurstofradicalen (p < .005) en snellere productie van
zuurstofradicalen (p < .005), dan polymorfonucleaire leukocyten samengebracht
met lange-keten vetten of structured triglycerides. Verdere studies toonden aan, dat
dit verschil in resultaat niet werd veroorzaakt door verschillen in de emulgator. De
overall productie van zuurstofradicalen was significant lager na behandeling van de
leukocyten met de drie vetemulsies, vergeleken met de controles zonder vetemulsie.
Geconcludeerd werd, dat het mengsel van middellange-keten en lange-keten vetten
leidde tot een snellere productie van zuurstofradicalen met hogere niveaus van
zuurstofradicalen, vergeleken met lange-keten vetten of structured triglycerides.
Dit kan enerzijds een nadelig effect hebben bij ziekten, waarbij zuurstofradicalen
een oorzakelijke rol spelen. Anderzijds kan dit ook een gunstig effect hebben bij
ziekten, waarbij het snel onschadelijk maken van bacteriën door zuurstofradicalen
noodzakelijk is. De hierna uitgevoerde studies door Wanten et al. bevestigden, dat
de interactie van middellange-keten vetten met immunologisch actieve cellen
duidelijk verschilt van lange-keten vetten of structured triglycerides. Verdere
studies met betrekking tot de klinische relevantie van deze observaties zijn
noodzakelijk. 
Recent zijn er meer studies met structured triglycerides gepubliceerd. Deze studies
worden in Hoofdstuk 9 vergeleken met bovenbeschreven studies. Tevens worden
hypotheses geopperd, die het gevonden verschil kunnen verklaren tussen de
stikstofbalans bij structured triglycerides en het mengsel van middellange-keten en
lange-keten vetten in onze patiëntengroep. 
Toekomst
Onderzoekers trachten steeds verder de vetemulsies in parenterale voeding te
verbeteren. Vetten zijn bijzonder interessante moleculen, omdat zij enerzijds deel
uitmaken van onze voeding, maar anderzijds ook farmacologische eigenschappen
hebben. Voorbeelden van deze farmacologische eigenschappen zijn effecten op het
immuunsysteem, op de aggregatie van bloedplaatjes, op de viscositeit van bloed en
op microvasculaire permeabiliteit. In de structured triglycerides die wij
bestudeerden zijn de midellange-keten en lange-keten vetzuren als bij toeval op
bepaalde posities aan het glycerol molecuul gekoppeld. Men kan echter specifieke
vetzuren op specifieke plaatsen aan het glycerol molecuul koppelen. Dit biedt de
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mogelijkheid om vetzuurpatronen samen te stellen, specifiek gericht op de speciale
behoeften van bepaalde patiëntengroepen, waarbij de eigenschappen van de
verschillende vetzuren optimaal benut worden. Een verdere mogelijkheid voor de
toekomst is de introductie van andere nuttige nutriënten, zoals glutamine, en zelfs
medicamenten in de structured triglycerides. Dat zal leiden tot de best denkbare
aanpassing van de eigenschappen van de parenterale vetemulsie aan de behoeften
van de patiënt: farmacologische parenterale vetemulsies.
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Stellingen
behorend bij het proefschrift
PARENTERAL STRUCTURED TRIGLYCERIDE EMULSION
Safety, tolerance, 
and effects on nitrogen balance and immunology
Joanna Kruimel, oktober 2004
1. Parenterale voeding met een structured triglyceride emulsie verbetert de
stikstofbalans en wordt sneller opgenomen uit de bloedbaan, vergeleken met
een mengsel van middellange-keten en lange-keten vetten, indien toegediend
aan matig katabole patiënten.
(Dit proefschrift)
2. Middellange-keten vetzuren bevattende parenterale vetemulsies hebben geen
nadelig effect op de fagocyterende functie van het mononucleaire fagocyten
systeem. 
(Dit proefschrift)
3. Tijdens een operatie wordt de ex-vivo productie van IL-1ß en TNF-α
onderdrukt, wat wijst op een downregulatie van de productie van deze
cytokines. Dit loopt parallel met de hormonale reactie met een hoog ADH en
ACTH, maar niet met cortisol, wat een aanwijzing vormt, dat
glucocorticoïden geen sleutelrol spelen in de downregulatie van productie en
vrijmaking van pro-inflammatoire cytokines.
(Dit proefschrift) 
4. Vetemulsies, bestaande uit een mengsel van middellange-keten en lange-keten
vetten geven aanleiding tot een snellere productie van zuurstofradicalen door
polymorfonucleaire leukocyten, met hogere niveaus van zuurstofradicalen,
vergeleken met lange-keten vetten of structured triglycerides. 
(Dit proefschrift)
5. De manier, waarop in the New England Journal of Medicine "Lorenzo's oil"
aanvankelijk bestempeld werd als waardeloos (N Engl J Med 329:745-752,
801-802,1993), gaat voorbij aan de geweldige prestatie van de ouders Odone,
die een veelbelovende behandelingsvorm voor adrenoleukodystrofie
ontwierpen.
6. Een vrouw, die een maatschappelijke carrière ambieert, is nu meestal
afhankelijk van geëmancipeerde mannen: een geëmancipeerde vader, een
geëmancipeerde echtgenoot en een geëmancipeerde werkgever.
7. Een ziekenhuis, waar zwangerschapsverlof  van artsen slechts op papier goed
geregeld is, maar waar in de praktijk geen enkele vorm van vervanging van
zwangere artsen georganiseerd wordt, voert geen goed emancipatiebeleid.
8. In een arbeidssector, zoals de gezondheidszorg, waar steeds meer vrouwen
worden opgeleid, zou in toenemende mate aandacht moeten worden besteed
aan een goede kinderopvang.
9. Oorlogsslachtoffers geven hun verdriet door aan hun kinderen, omdat het
lijden niet vergeten mag worden. Niets kan het lijden uit het verleden zijn
zinloosheid ontnemen, alleen kan men trachten in het heden herhaling te
voorkomen.
10. Fanatisme bestaat, omdat we behoefte hebben aan simpele antwoorden op
gecompliceerde problemen (D.C. Dennett in t.v. programma W. Kayzer, 10-
01-1993).
11. De pathofysiologische basis voor verslaving aan een geliefde en "mourir
d'amour" is waarschijnlijk te vinden in een door verliefdheid geïnduceerde
neuroendocriene stress respons met vrijmaking van endorfines en een
immunologische stress repons met verminderde afweer tegen infecties (eigen
observatie).
